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I. Introduction
The Great Lakes ecosystem continues to feel pressure from man's

activities.

Perturbations caused by population growth and increased

industrialization have been shown to cause adverse effects on various sections

of the ecosystem and the potential exists for adverse human health effects
from microbial contamination of water and chemical pollutants in water and
fish.

Clearly, the potential health impacts of pollution within the Great Lakes

is of great concern to all residents within the basin. The public is well
aware that several hundred synthetic organic chemicals have been identified in
the Great Lakes Basin Ecosystem and it has expressed some fear that drinking

water supplies in the basin pose a significant health hazard.

In an effort to

ascertain whether such fears are based on fact, the Committee reviewed the
information available on Great Lakes drinking water quality and the potential
for adverse health effects.
This report discusses various aspects of Great

Lakes water quality, including the role of newly developed, short term,
mutagenicity tests in the assessment of the potential

impact of drinking water

on man's health and the threat to human health from microbial contamination of
drinking water and recreational waters. Also discussed are the merits of
adopting watershed protection policies in safeguarding public health. The
Committee also provides in this report an evaluation of newly-developed
techniques to measure the potential of chemicals to affect the mammalian

immune system. Such procedures may play a significant role in future
toxicological research on chemicals identified within the basin.

During l982 the Committee sponsored a Roundtable on the Surveillance and
Monitoring Requirements for Assessing Human Health Hazards Posed by

Contaminants in the Great Lakes Basin Ecosystem. The Proceedings of the
Roundtable were prepared by the participants. A summary of the major points

of this report is provided by the Committee with the intent that those who are

initiating or reviewing programs designed to assess man's exposure to
environmental contaminants will be able to provide data that are more
appropriate for future health hazard assessments.

Finally, the Committee has provided additional clarification of its hazard
assessment of Great Lakes chemicals. In the l98l report of the Committee,
chemicals identified within the Great Lakes Basin Ecosystem as of l978 were

classified according to their potential impact on human health. Several
aspects were considered by the Committee, including newly-found data on
toxicity and exposure which have been evaluated and the Tables from last
year's report modified accordingly. These updated Tables should be of greater
utility to managers of toxic chemical programs within the basin.
The recommendations of the Committee are reproduced in Chapter 8.

2.1

2. Drinking Water and Public Health

INTRODUCTION

Until the last few years, residents in the Great Lakes Basin had assumed
that their abundant fresh water resources were safe from the adverse effects
of population growth and increased industrialization.
Population growth and

industrialization can result in pollution of drinking water sources.

As the

quality of the source water and/or drinking water deteriorates, the potential
for the occurrence of disease and infection due to pathogenic organisms such
as bacteria, viruses, protozoans and helminths and the toxic effects of
chemicals, increases.

The public has, over the last few years, become better informed regarding
the numbers of chemicals identified in drinking water and has continually
voiced concern over the fact that many identified chemicals cause chronic
adverse biological effects in mammalian species.

Hence the potential

long term health effects of the chemicals found in drinking water are of
concern.
The Health Effects Committee addressed the subject of drinking water and
human health in an attempt to delineate the extent of any health risk from

present drinking water quality, both chemical and microbiological.

2.2

CHEMICAL CONTAMINANTS FOUND IN DRINKING WATER FROM THE GREAT LAKES
All drinking water produced from sources within the Great Lakes Basin

normally contains a complex mixture of chemicals.

These chemicals and

elements are of natural origin or a direct result of man's activity.

Many of the inorganic elements are of negligible toxicity and are in fact
essential to man (e.g. calcium, zinc and magnesium). Others are recognized
toxicants (e.g. lead, cadmium and arsenic). In addition to the inorganic
elements found in drinking water, particulate matter including asbestos has
also been detected.
Many organic chemicals have been identified, some of natural origin (e.g.
humates), while others arise solely from man's activities (industrial and

municipal waste discharges, hazardous waste disposal and water treatment
processes).

There is a wider diversity of organic than inorganic compounds

found in drinking water.
In fact, a large proportion of the organic fraction
of drinking water has yet to be identified. Also, many of the organic
chemicals have unknown toxicity.

In general, the inorganic elements have been monitored for decades and

health related standards set fer the major toxic elements. No adverse health
effects have been reported as a result of toxic inorganic elements in drinking
water within the Great Lakes Basin. Most recent public concern has focused on
the many organic chemicals found in drinking water.

Worldwide, over 700 organic chemicals have been identified in man's

drinking water.

Many of these chemicals have been identified in samples of

drinking water from the Great Lakes. Drinking water guidelines and/or
standards have been set for only a few of the identified organic chemicals.

However, surveillance studies within the Great Lakes Basin indicate that
organic chemicals in drinking water are present at the low parts-per-billion

level or less.

The need for drinking water guidelines or standards for

newly-identified chemicals may be ascertained by such factors as:

)

ambient levels in raw and finished water;

)
)

physical and chemical properties; and
evidence of toxicity in animals or man.

)

industrial production and use

data;

Surveillance for presently unidentified organics must be encouraged in
addition to the continuation of compliance monitoring. Guidelines for
surveillance and monitoring of drinking water and drinking water supplies are
referred to in the Proceedings of the Roundtable on the Surveillance and
Monitoring Requirements for Assessing Human Health Hazards Posed by

.

Contaminants in the Great Lakes Basin Ecosystem (l).

2.3

DRINKING WATER CONCERNS-MICROBIOLOGICAL

The principal objective of drinking water treatment is the elimination of
macro- and micro-organisms capable of causing waterborne disease. Such

organisms
dependent
effective
organisms

may be found in surface and ground waters at all times, in numbers
Major outbreaks are prevented by
upon the degree of contamination.
disinfection procedures. The inactivation of waterborne disease
remains of paramount importance for the protection of public health.

A number of synthetic organic chemicals has been found in water supplies.
Some are present in the source waters, others are produced as a result of

disinfection or other treatment processes.

There is a lack of definitive

evidence that these substances, in the concentrations found in most waters,

are harmful although prudence would dictate that levels be kept as low as
possible. The levels of these contaminants can be reduced by the use of
carbon filters or by alteration of the type of disinfecting agent or its point
of application.

Whilst such modifications may remove the contaminants, or

reduce the amounts produced, they may also compromise the microbiological

safety of the produce water, even to the point of creating a serious health
hazard.

The danger lies in the potential for multiplication on the carbon filters
great variety of microorganisms which occur in natural waters. In
a
of
addition, so-called aftergrowth of these bacteria in the distribution system
may occur if carbon filters or other measures cited above have resulted in a
decrease or elimination of residual disinfectant. The types of bacteria
involved in such growths include several opportunistic pathogens (also
referred to as secondary invaders) which are harmless to most humans,

particularly when present in small numbers, but which can be very
individuals with lowered resistance and generally to the aged and
young. The reduction of residual disinfectant levels affects the
of pathogens which may have entered a distribution system through
(l)

dangerous to
the very
elimination
loss of line

IJC Health Effects Committee, held March l7-l8, l982, Michigan State

University, East Lansing.

'

pressure, cross connections, or as the result of other imperfections either in

the treatment or in the distribution system (2)(3).

A modification in water

plant treatment practice may therefore eliminate one potential public health

concern at the expense of creating the very real hazard of acute waterborne
illness. It follows that water purveyors and regulatory agencies must
carefully weigh the benefits and dangers of any process modification.
Particular caution is in order with regard to the use

of "point-of-use

water purifiers, i.e., filters which are installed on individual household
taps.
These units may be purchased by consumers who are confused and

concerned by press reports and advertising material and who respond to an
exaggerated or totally unsubstantiated fear of contamination of a local water
supply.

Manufacturers do not acknowledge local and regional variations in

drinking water quality.
Theconsumer usually has insufficient information on
which to base an intelligent decision on the desirability of point-of-use
treatment or the type of units suited to a particular need.

Many contaminants

which may be of concern are not amenable to the treatment these units provide.
Further and most importantly, the use of these devices may create
hazardous situations in that large numbers of bacteria may be able to grow

within the units and may leach from them into the product water.

Hence, the

performance of these units depends greatly on the chemical and microbiological
characteristics of the water supply.
Adequate monitoring, which would assure
the effective and safe operation of these devices is rarely, if ever, provided.

If a serious chemical contamination problem exists it could be dealt with
effectively and in a timely fashion by the installation of point-of-use
filters.

By this is meant that contamination has been detected and that it is

amenable to this form of treatment and that centralized treatment or an
alternate source of water cannot be provided. Public Health authorities are
in a position to determine if and where such a situation exists.

If

point-of use devices are installed, an adequate monitoring program should be
instituted to assure safe operation. In addition, a schedule for the
replacement or regeneration of the filters appropriate for the specific
situation should be instituted and adhered to by the households affected.
2.4

PREVENTIVE MEASURES: WATERSHED PROTECTION

An important element in the protection of drinking water quality is the
protection of the source, be it ground- or surface water.
This principle has
been applied for many years in the prevention of waterborne infectious

disease. The vastly increased production and use of synthetic organic
chemicals has added new significance to this concept, but, unfortunately few

jurisdictions have developed the administrative tools to apply it effectively.

(2)

Tobin, R.S., D.K. Smith and T.A. Lindsay (l98l). Effects of activated
carbon and bacteriostatic filters on microbiological quality of drinking
water. App. Envir. Microbiol. 41:646-65l.

(3)

Environmental Health Directorate (l977). Survey and test protocols for
point-of use water purifiers. Report No. 77-EHD-8 Health and Welfare
Canada, Ottawa.

According to a recent study (4) the first municipal watershed rules and

regulations in the United States were enacted by the City of Philadelphia in
Subsequently other
l828 and by the Commonwealth of Pennsylvania in l832.
source protection
supply
water
for
states have passed enabling legislation

rules and regulations, but

the degree of implementation on the state and local

In some jurisdictions watershed rules are enacted only
levels varies greatly.
upon application by a water supply or a locality and enforcement responsi
bilities may lie either with a water district, a municipality, or the state.
Small supplies and localities often are poorly equipped to enforce their own

watershed regulations.

Historically, watershed protection measures were designed to prevent

contamination of the source with fecal and other readily biodegradable sewage

matter. This explains why many regulations address only pollution sources in
the immediate vicinity of the well or water intake. Often they do not address
the safety of aquifers which may become sources of drinking water in the
future and often they rely on conventional municipal wastewater treatment for
the control of upstream pollution of surface waters. Many harmful synthetic

organic chemicals either are much less biodegradable than fecal matter, or are
not biodegradable at all. Others are biodegradable only in oxygenated waters,
hence degradation is limited to rivers, some lakes and shallow groundwater.

Several common chlorinated organic solvents are even metabolized in
groundwater to vinyl chloride, a proven carcinogen.

Groundwater pollution occurs across water district and other jurisdictional
boundaries.

In the past, most drinking water problems could be solved by appropriate
water treatment and the significance of watershed protection measures was
mostly in erecting a second barrier against infectious disease. Currently,
watershed protection has become a critical requirement for maintenance of

acceptable potable water quality. The removal of trace concentrations of
synthetic organic contaminants from drinking water can be so expensive that it
has been proposed to install dual water systems in areas thus affected, one

water system delivering highly treated water for drinking purposes only, the
other, less well treated, for all other uses.
Watershed regulations prohibit activities within a watershed which

endanger the quality of the source water. The increase in production, storage
and use of persistent synthetic organic chemicals has vastly increased the
number of incompatible uses, which include not only the large-scale
manufacture, transport, storage and waste disposal but also the unsafe

handling of small amounts as found, for example in most households. The
danger becomes clear to anyone who visualizes that a contamination level of
O.l ppm (parts-per-million) corresponds to one liter (or kilogram) of a

compound distributed over a volume of water which can serve a family of four

for 30 years. Standards for very toxic contaminants are set at even lower
levels. This illustrates that drinking water reserves, particularly

groundwater resources, require very careful protection in order to remain of
acceptable quality.

(4)

Hennigan, R.D., et_al,, (l98l) "Water Supply Source Pollution Rules and
Regulations".

Report prepared for the Planning Section, Bureau of Public

Water Supply, NY State Dept. of Health, Albany, by the Graduate Program in
Environmental Science, State University of New York College of
Environmental Science and Forestry, Syracuse, NY.
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The Great Lakes and other surface waters are characterized by a great
potential for the "assimilation" (degradation, inactivation) of waste
material. Also, many contaminants pass through without ever reaching the
drinking water intakes.

Watershed protection for the purpose of preserving

the Great Lakes as a source of drinking water thus requires strict limitations
on discharges from all materials which are not sufficiently degraded or
inactivated.

The Committee, in its l98l Report and in sections of this Report recommend
surveillance for certain substances of concern which are either
non-biodegradable or which are biodegradable but discharged in amounts large
enough to be detected at locations for removal from the point of discharge.
The stakes are high: if Great Lakes water should become more contaminated and
unsuitable for drinking, or very expensive to treat, most urbanized areas in

the Great Lakes Basin would have great difficulty in locating alternative,
safe sources of water.
2.5

STATUS AND CONCLUSIONS

The Committee is aware of large data bases on health statistics within the
basin and the results of epidemiology studies throughout the United States
which attempt to correlate drinking water quality (particularly the level of
certain organic chemicals) and human health status. Such studies are
extremely complex and should not be subjected to a cursory review by
non-epidemiologists. Although studies to date appear to neither support nor
refute positive animal cancer bioassays, the Committee will ask for expert

advice from a group of epidemiologists before reaching a final conclusion
regarding this important area of research.

Currently, the public health hazard posed by microbiological contamination

of drinking water carried out within the Great Lakes Basin is extremely low.

Given present day drinking water technology, this situation should not change,
unless arbitrary decisions are made to alter present disinfection procedures.
Adequate public health protection requires drinking water free from microbial
contamination and any attempt to lower the trace levels of organic chemicals
in drinking water must not compromise this requirement. The efficacy of any
newly developed disinfection technique must be ascertained under field
conditions before adoption.
Present data on the levels of organic chemicals found in drinking water
supplies within the basin and the known toxicity of many of these chemicals,
do not indicate an emergency-type public health problem. However, given the
amounts of hazardous wastes stored around the Great Lakes and the increasing
demand by society for synthetic chemicals, there may well be an emerging
public health problem. Prompt remedial actions on hazardous chemical dump

sites and improved effluent controls are required.

Many investigators have attempted to use microbial mutagenicity tests to
delineate human health hazards from chemical exposures. Such a procedure is
not supported by known physiological differences between bacteria and mammals
and between the biological response to chemicals of isolated bacterial cells
and whole animals. Short-term bacterial tests are extremely valuable for
setting priorities for future studies, but the actual hazard to man of

chemical contaminants can only be determined, at this time, by experiments in
whole animals or by large-scale, well-designed epidemiological studies.

2.6 RECOMMENDATIONS
Chemical
1.

2.
3.

Surveillance of drinking water supplies for new organic contaminants must

be increased.
The Parties should augment present toxicology programs to study the
toxicity (including carcinogenicity) of chemicals identified in drinking
water supplies within the Great Lakes Basin.
More emphasis should be placed on the toxicological evaluation of the

non-chlorinated organic chemical fraction fron drinking water.
Microbiological

4.

Modification of drinking water treatment plant operations should be
undertaken with caution and on an individual basis following adequate
studies to determine:
a)

b)
5.
6.

7.

the efficacy of the modified treatment process in removing
contaminants of concern; and

the impact on the microbiological quality of the product water both
at the plant and, more importantly, in the distribution system;

Point of use water treatment units should be used only where conventional

approaches are not applicable and then only with an adequate monitoring
program and regeneration/replacement schedule;
Additional research into the relationship between particulate

matter/turbidity and waterborne illness, especially in recreational
waters, should be undertaken to determine whether improved particulate
removal during sewage and stormwater treatment should be recommended; and
The jurisdictions should be urged to recognize the need for the assessment
of chronic health problems from low level exposure to microbiological
contaminants.

3. Recreational Water Quality
3.1

INTRODUCTION

In its 1981 Report, the Committee dep1ored the inadequacy of the current

scientific basis for regu1ating recreationa1 water qua1ity. Resu1ts of a
recent study (Dufour, 1982) shed new 1ight on the issue. A brief account
fo11ows.
3.2 DISCUSSION
Regu1atory agencies decide upon the suitabi1ity for swimming of

recreationa1 waters on the basis of standardized bacterio1ogica1 tests for
indicator bacteria. Reports on swimming-re1ated gastrointestina1 i11ness,

however, show on1y a weak correlation, if any, with indicator bacteria1
densities.
In addition and independent of indicator bacteria1 densities, an
increased risk seems to be associated with exposure to untreated municipa1
wastewater (Committee on Bathing Beach Contamination, 1959).
Severa1
jurisdictions make sanitary surveys a part of their recreationa1 water

survei11ance and ban swimming near outfa11s of untreated municipa1 wastewater
or near active combined sewer overf1ows.

The infectious dose for pathogenic microorganisms varies with species.
For many sa1mone11a bacteria it is in the order of 105 - 106 bacteria

(Dud1ey, et a1., 1976) whereas for shige11a a 1ower infectious dose (102 -

103 bacteria)_has been postu1ated (Levine, gt_al,, 1973).

Estimates of

pathogen density in recreationa1 waters which meet or s1ight1y exceed current
co1iform standards, suggest that a swimmer must ingest a substantia1 vo1ume of
water in order to acquire an infectious dose (Fuhs, 1975). In a11 such
ca1cu1ations it is assumed that the pathogens and the indicator bacteria occur
sing1y, not in c1umps. The prob1em is that in many instances this assumption
may not be correct.
A sing1e feca1 partic1e derived from a person suffering

from gastrointestina1 i11ness conceivab1y can contain a 1arge number of
bacteria or viruses sufficient to constitute an infectious dose. In the case
of intestina1 viruses, the 1ike1ihood that they remain c1umped and associated
with ce11 debris is very great (We11ings, et_al., 1976, F1oyd and Sharp,
1977).
In fact, it is entire1y possib1e that c1umps of virus partic1es are
the most important cause of swimming-re1ated gastrointestina1 i11ness. The
same may app1y to the pathogenic bacteria as we11. In the presence of such
feca1 partic1es, infections can occur even at re1ative1y 10w 1eve1s of
indicators and/or pathogens per unit vo1ume of water when tested. The
increased resistance to inactivation by ch1orine of bacteria and viruses which
are associated with or enc1osed in organic matter is an exacerbating factor
(Boardman and Sprou1, 1977; Young and Sharp, 1977).
A recent report by Dufour (1982) suggests the answer to the question of
the poor corre1ation between indicator bacteria1 densities and

swimming-re1ated disease and it is concerned with the turbidity and

particu1ate content of the water.

BacteriaT counts in recreationa1 waters

were obtained after fi1tering the samp1es through 3pm membrane fi1ters.

In

addition, the 3pm fi1ter was processed to show indicator bacteria associated
with partic1es retained by the fi1ter. The count of these partic1es, which
are presumab1y of feca1 origin, was more c105e1y corre1ated with subjective1y

perceived gastrointestinal symptoms than was the number of bacterial
indicators determined along conventional lines.
This seems to support the
foregoing hypothesis. However, the new method is still extremely crude and
the following caveats apply.

Particulate matter may be reworked in the aquatic environment in many

different ways as follows:

0

0

wastewater treatment plants depending upon

the type of treatment,

proouce biological floc or chemical precipitates.
Both types of
particulates may have indicator bacteria adsorbed to them but do not
necessarily contain clumps of pathogenic bacteria or viruses;

in all surface waters, new particulates form from material in the

surface microlayer (see Fuhs, l982) and by microbial action in the
sediments.
These new particles also may have indicator bacteria

attached to them in numbers possibly unrelated to the numbers of

o

pathogens present; and
in estuaries, new particulate matter is formed in large quantities by
coagulation processes, unrelated to sewage contamination.

The assumed relationship between risk of infection and particulate matter

will hold less where these mechanisms come into play.

There have been

observations that pathogens persist in sediment (Van Donsel and Geldreich,

l97l), but

understooo.

the correlation with indicator bacterial densities is poorly

Additional research is required to yield final clarification of the
relationships between particulate matter, turbidity and illness.
But in the
interim it would appear that recreational waters could be protected by
improved particulate removal at wastewater treatment plants and from combined
sewer overflows.
thorination of sewage effluents has come under attack for
good reasons. With improved particulate removal, it would seem that the risk

of infection may be reduced even without chlorination and if chlorine is

applied, a relatively small dose would be sufficient to reduce the number of

unprotected bacteria or viruses.

It should also be noted that particulate

removal is an important consideration in the removal of phosphates from
wastewater effluents.
/

3.3 RECOMMENDATIONS
A more rational basis for our understanding of health risks from swimming

should be obtained through additional research.

It appears that safe waters

for swimming can be provided without excessive reliance on the chemical
disinfection of wastewater effluents.
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4. Invited Paper: Studies of Drinking
Water Mutagenicity
INTRODUCTION

studies in bacteria are carried out, some of the results obtained and the
proper interpretation of such data relating to mutagenic activity in drinking
water.

Municipal drinking water in the United States and Canada is usually

new , Mama ,

The purpose of this chapter is to discuss studies on the mutagenicity of

drinking water in the bacterial system Salmonella typhimurium. Results from
such mutagenicity tests have been shown to be useful in predicting the
carcinogenic potential of chemicals. This chapter discusses how mutagenicity

_ A7.,....,.,......,_ ..,A.,.- V 0 y.
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4.1

supplied by nearby rivers or lakes which contain varying amounts of natural

and synthetic organic compounds. Hundreds of chemicals have been detected in
drinking water and many of these are formed by reactions of the constituents
of the untreated water with chlorine during disinfection. Certain of these
compounds (e.g. dichloromethane and chloroform) are known to be mutagenic
and/or carcinogenic in experimental organisms at doses many thousands of times
greater than the trace levels to which people are exposed through the water
supply.

Is it possible that trace levels of chemicals in drinking water can
contribute significantly to our overall burden of chemical mutagens and/or
carcinogens? North Americans are exposed to many chemicals in varying
amounts, such as food additives, drugs and pesticides, products used in

hobbies and the household, solvents, exhaust gases, cigarette smoke and
occupational chemicals in the workplace. In relation to these, drinking water
is a very minor contributor to our overall chemical exposure, but it is a
source of chemicals to which all who drink tap water are exposed for a
lifetime. Therefore, it is important to enter into research programs to study

the possible toxic potential of drinking water. One approach has been the use
of sensitive bacterial assays that are capable of detecting low levels of
mutagens (potential carcinogens) in environmental samples.

It is imperative to acknowledge that screening drinking water or extracts
of drinking water for bacterial mutagenicity is not a reliable way to
determine safety or hazard of any drinking water source. Materials that are
mutagenic in bacteria are not always mutagenic or carcinogenic in whole
animals (and vice versa). There are many reasons for the differences,
including tissue distribution, metabolism and DNA repair. Bacterial testing

is valuable for setting priorities for further investigations, but human risk

must be determined on the basis of i _VlV0 mammalian studies.
4.2

METHODOLOGY
The most commonly used bacterial test system is the Salmonella/mammalian-

microsome assay for the detection of point mutations. Many chemicals that are
mutagenic in this assay also induce mutation and cancer in rodents. A high
correlation between Salmonella mutagenicity and carcinogenicity has been

noted, although percent correlations vary
for study.

withthe types of chemicals chosen

The value of this test in general

is enhanced by the incorporation

of a mammalian microsomal activating system, in the form of a rat-liver
l3
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homogenate ($9).

This material contains enzymes which can convert promutagens

into genetically active mutagens, detectable by different types of reversion
mutations in different strains of Salmonella typhimurium. 0f the five
standard tester strains for Salmonella, most testing of drinking water
extracts involves only the two most sensitive, TA98 for detection of

frameshift mutations and TAlOO for base substitution mutations.
Although the
extent of mutagenicity testing is limited by the milligram quantities of
extracts available, an effort must be maoe to look for dose-related increases

in mutagenic activity with some lethality at the highest dose(s).

The criteria used by most investigators for deciding what may be regarded

as a positive response in Salmonella, involve at least a doubling of the
spontaneous background of mutants and evidence of a dose response

(dose-related increases of mutantslf_ A result is judged to be negative when

both conditions are not fulfilled.
These criteria are embodied in what is
referred to as "The Modified Two-Fold Rule", which has been found to be the
most sensitive index of true positive and negative responses compared to other
biological and/or statistical analyses.
One approach to bacterial mutagenicity testing of drinking water has been

to test unconcentrated water, just as it comes out of the tap, using the
Salmonella assay or a more sensitive fluctuation test (a liquid culture assay
with 50 replicates per dose). Such studies on unconcentrated water samples,
whatever the source, lead to variable results.

If unconcentrated samples cannot be used reliably, what approach should
then be taken? It is not practical to test all known constituents of drinking

water for possible toxic effects, nor is it practical even to identify every
contaminant that is present in trace amounts. Consequently, attempts are

underway to study the mutagenic potential of drinking water by testing
concentrates or extracts. By extraction and concentration, enough material is
obtained to produce measurable mutagenic activity even in the least
contaminated types of drinking water.

With this approach, one can then make

comparisons of the level of mutagenicity in different locations and

seasonally, etc., provided that the concentration steps are sufficient to
produce detectable mutagenicity in most extracts.
In addition, this procedure
permits testing of chemical doses which meet internationally accepted
protocols for the S. typhimurium assay.
One of the most widely adopted methods for selectively concentrating

certain of the non volatile dilute organics present in drinking water is the
use of XAD macroreticular resins. The classes of organics that do not adsorb

to XAD-2 (or -4/8) do not seem to be major contributors of mutagenic
activity. XAD resins can be conveniently used in laboratory or field stuoies
if they are placed in cartridges to be connected to taps or pumps which supply

water at constant flow rates.

The columns can be eluted with solvents (e.g.

acetone and hexane), with an evaporation step before testing, or elution can

be done with the test solvent itself, dimethylsulfoxide (DMSO).

A problem

with both methoos is the possible interaction of the test material and
solvent, as has been shown for certain compounds and the changing properties
of extract solution stored in DMSO.

An approach to overcome some of these problems has been to split the XAD
eluent, take half to dryness (dissolved in DMSO) and reduce the volume of the
other half (by evaporation) for direct testing without DMSO. Comparisons have
l4

been made of the initial slopes of the dose-effect curves for such dry and
liquid extracts from the same samples.
In certain cases little or no

difference between slopes is observed, which probably means an absence of

interaction of the dry extract with DMSO; however, for other samples, the
initial slopes do not overlap, indicating that choice of solvent does
contribute at times to the pattern of extract mutagenicity observed.
In
addition, extracts of water in dimethylsulfoxide show reduced mutagenicity
after storage for 2-3 days.
These findings emphasize the importance of being

cognizant of possible solvent effects.

4.3.

MODEL STUDIES

Using the general methods and criteria described above, many studies have

been performed on water supplies in Europe, Africa and North America. For the
purpose of the International Joint Commission, perhaps the most pertinent
investigations are those involving samples from 45 treatment plants throughout

Canada, including l2 municipalities using the Great Lakes as the source of

drinking water. Since previous studies have shown that the mutagenicity of
samples varies from season to season, all plants were sampled twice during the
year (usually August/September and November/December).
Positive effects were

found for at least one sample from 44 to 45 treatment plants. Since drinking
water from the Great Lakes has been reported to contain levels of
anthropogenic compounds lower than those found in drinking water from river
sources, comparisons of mutagenic potencies were made amongst the three types

of water sampled (river, lake, well).

Average mutagenicity of the extracts

was higher in the summer samples for each of the three types of water and the

mutagenic activity found in concentrates of organics from well water was lower
compared to river or lake sources.
No consistent difference in the
mutagenicity of extracts was apparent between rivers and lakes since extracts

of river sources on the average were more mutagenic in winter and less in
summer. The same pattern was found when the Great Lakes sources were
considered separately and compared to river sources.

The mutagenic potencies of extracts from different locations varied

considerably and efforts have been made to relate mutagenicity with treatment
parameters and the presence of various chemicals.
In a Great Lakes study of
l2 municipalities, no compelling trends were apparent.
In a Cross Canada
Survey, the potency and analytical data were analyzed with the help of a

computer.

The highest correlations were found with non chlorinated aromatic

compounds (e.g. ethyl benzene, toluene and xylenes).
Coefficients of
correlation with trihalomethanes, chemicals that have been the subject of much
recent concern, were lower.
It has been shown that a compound responsible for

much of the mutagenicity in some extracts of Cincinnati drinking water was

also non-chlorinated.
Such results indicate the need for additional
toxicity/mutagenicity studies on the non-chlorinated organic compounds found

in drinking water.

Another finding of interest in these studies concerned the role of a rat

liver enzyme preparation (59) for mammalian metabolic activation in the

_

.

bacterial assay. In no case did 89 enable the detection of mutagenic activ1ty
of an extract that was negative without 59. Furthermore, the presence of 59
generally reduced the mutagenic responses observed in its absence.

l5

4.4

CONCLUSIONS

Results from such studies can be interpreted to mean that drinking water
contains trace levels of compounds that, when concentrated 5 x 104-f01d, are
likely to be mutagenic in a bacterial screening test.
It is often concluoed

that differing amounts of these compounds in the extracts can lead to

different levels of mutagenic response, although it must be noted that when
complex mixtures of componds are tested, many additive, synergistic and
antagonistic interactions may take place.
It cannot be assumed that the same
interactions that occur in the Salmonella test will occur in other
mutagenicity assays or in the whole animal.

For the interpretation of data from bacterial mutagenicity studies, it is

important to recognize their preliminary nature.
Screening and monitoring
experiments with bacteria may provide the initial warning of a potential
problem, but comprehensive evaluation of a drinking water source for its
chemical safety must include data from an appropriate battery of short-term
studies followed, when needed, by jn_vivo animal bioassays.
Thus, a maJor
value of bacterial testing is to enable investigators to identify particular
water sources or types of treatment for further assessment by other methoas

for the ultimate goal of determining human risk.
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Antigens are found on and in cells and infectious agents, or may be defined

chemical entities.

Antibody production usually requires the participation of

macrophages (as accessory cells) and two types of lymphocytes, B(bursal)-cells
and T(thynus)-cells.

The nomenclature of the two large lymphocyte classes

referred to above is derived from anatomic sites or equivalents through which
young cells pass during maturation. Upon encountering an antigen, macrophages
are believed to process and

'present' it to T cells (l0) and to release a

variety of chemicals among which are stimulators of T-cell divisions (reviewed
in ll). Antigen-responsive T-cells are generated during this process and in

turn, release other chemicals known as lymphokines which enhance or suppress
the responses of other participating cells (l2).
In general, two subtypes of

antigen-specific T-cells result from cell division: T-cells which provide
"help" to the precursors of antibody-producing cells and T-memory cells that
revert to a quiescent stage, forming a pool of antigen specific cells capable

of rapid numerical growth on re exposure to the antigens

(l2).

B-lymphocytes

respond to antigen by undergoing differentiation to either end-stage plasma
cells which synthesize antibodies or to B memory cells.

Cells of the T-lymphocyte lineage are also the effectors of cell mediated
immune responses. Although antibodies are produced by cells, the distinction

drawn by immunologists between humoral and cellular immunity is the ability to
transfer humoral immunity to an antigenically naive recipient with cell free,
antibody-containing serum. Cell mediated immunoreactivity can be transferred

by immune T-cells.
In very recent years, the use of sophisticated techniques
has demonstrated numerous subsets of T-cells.
Classification systems have
attempted to describe subsets of T-cells which respond to tumor cells, foreign

tissue antigens and infectious agents.

Delayed hypersensitivity (e.g. poison

ivy, positive tuberculosis skin test), so-called because of the time (usually
approximately 48 h) between antigen contact and host response, is also

mediated by T-cells. This response, while usually beneficial to the host
(e.g. during parasitic and bacterial infections) also is the pathologic basis
of certain diseases, including tuberculosis and poison ivy.

5.3 ALTERATION OF THE IMMUNE SYSTEM
A variety of methods has been applied to assess levels of immunocompetence
in humans and experimental animals.
Some of the most widely employed assays

are briefly described in Table 5.1. There is a variety of advantages and
disadvantages in all of the assays described. However, the host resistance

assays provide the greatest overview of immunocompetence since they depend on

a multicompartmental response by the entire organism rather than by cultured
cells. In addition, these assays directly reflect the integrity of the major

functions of the immune system, i.e. controlling infection and neoplastic cell
proliferation.
It should be noted that while the tests for immune competence

listed in Table 5.l have been accepted as scientifically valid and provide an
insight into the toxic mechanism(s) of tested compounds, at this time such
tests are not used as a basis for regulatory decisions.

A variety of chemical agents is known to affect immunocompetence.
Therapeutic manipulation of the immune system is a common tactic in combating
certain disease processes that result in an immune response against the self

(e.g. in rheumatoid arthritis).

Deliberate local or systemic suppression of

the immune response is also employed to control such diverse responses as the
itching and swelling characteristic of mosquito bites and poison ivy or the
life-threatening events accompanying acute rejection of organ transplants

l8

TABLE 5.]

SELECTED ASSAYS FOR EVALUATION OF INMUNOCOMPETENCE

ASSAYS

TYPE.l

IMMUNE FUNCTION ASSESSED

COMMENT

In vivo,
spec1f1c

"Whole Body

Antibody production

In vivo,
spatiiic

Production of antibody to a
specific antigen

Antibody production is stimulated in test animals
by antigen injection and is measured in vitro

Delayed hypersensitivity
response

En vivo,
spec1fic

Cell mediated immunity

Evaluates a portion of the complex responses known as
cell mediated immunity

Lymphocyte proliferation

In vitro,
non-specific

Proliferative capacity of
T-cells and B-cells

Provides a general indication of the ability of cells
to divide when stimulated with powerful, non specific
agents

Cell mediated

in vitro,
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Host resistance

cytotox1city

Phagocytosis

immunity

Destruction of tumor cells

Tumor cells, bacteria, viruses, and parasites, are
used to challenge animals and tumor development, time
of recovery from infection and/or death rate is
recorded.

Reflects the integrity of a

first line of defense"

specific/
non-specific

by natural killer cells or
T killer cells

against tumors (NK cells) and antigen-specific
immunity to tumors (T killer cells)

In vitro,
non specific

Engulfment of target cells
by macrophages or

Measures capacity of phagocytic cells to engulf
bacteria or other targets, which may or may not be

neutrophils

pre-coated with antibody (see text)

1Specificity indicates responses to a particular antigen; non specific responses are generally
directed against a group
characteristic rather than an individual characteristic such as an antigen.

(reviewed in l3).

Numerous agents are capable of inducing immunosuppression

by a variety of direct and indirect mechanisms (l4,l5,l6,l7).

Depression of

natural killer cell activity, antibody production and delayed hypersensitivity
responses can occur after exposure to these agents (l8,l9,20). Thus, both
antigen specific and non-specific responsiveness can be deliberately altered.
It is now readily apparent that some environmental contaminants are
immunotoxic.
For example, benzo(a)pyrene, a ubiquitous and potent carcinogen,
depresses humoral immunity in adult mice (2l); an effect which persists for at
least 3/4 of the adult life span if exposure occurs jn_utero (22). The

association of immunosuppression and carcinogenicity has been reported for a

number of compounds (23).

induction,

Immunosuppression appears to precede tumor

since decreased immunity has been observed during the entire latent

period between chemical exposure and the development of cancer in laboratory
animals (24,25).
In contrast, exposure to non carcinogenic forms of the same

compounds does not affect immunity (2l,23). These findings are in accord with
the theory of immunological surveillance which states that most malignant
cells are antigenically distinct from normal cells and are therefore
recognized and destroyed by the immune system; suppression of immune
surveillance will therefore likely result in an increased tumor incidence
(26). while this system as originally proposed has a number of shortcomings

(27), it has become obvious that tumor incidence is increased in patients
administered immunotoxic drugs to maintain tissue grafts (28). Furthermore,

fetal, neonatal and very

agedanimals display

reduced immunocompetence

compared to normal adult mice and are more susceptible to chemically-induced
tumors during these periods (29). It has also been determined in humans that
infectious diseases increase during chronic immunosuppression.

Thus,

infection with bacteria (30), protozoa (3l) or nematodes (32,33) that are
usually well tolerated may become pathogenic or be fatal to the compromised

host.

There have been many attempts to determine whether experimental exposures

to environmental contaminants can reduce immune functions. To date, numerous
reports have shown this to be the case.
For the sake of brevity, a

representative sample of these reports are summarized in Table 5.2.
listing is by
performed.

This

no means complete, either in the compounds tested or the assays

Immune system dysfunction in humans exposed to environmental contaminants

is not well documented.

However, an anecdotal report indicates suppressed T-

and B-cell growth in Michigan dairy farmers exposed to polybrominated
biphenyl(PBB)-contaminated meat and dairy products (49). Likewise,
immunologic evaluation of patients with "oil disease", an acne-like skin
disease due to polychlorinated biphenyl(PCB) contaminated cooking oil in

Taiwan, revealed suppression of delayed hypersensitivity, T cells and serum

immunoglobulin levels (49,50).

5.4 SUMMARY
The immune system is responsible for protecting the host from infectious

agents and has a role in resistance to cancer. Suppression of these
protective functions may result if cells are unable to either recognize or

respond properly to antigens.

Immunosuppression may also result from lysis of

immune cells by toxic materials or drugs.
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TABLE 5.2
EFFECTS OF SELECTED ENVIRONMENTAL CONTAMINANTS 0N IMMUNE FUNCTION OF EXPERIMENTAL ANIMALS

DeTayed
Hypersensitivity

Agent
DiethyTstibestrOT

(DES)

Function of
T-ce115

B-ce115

Accessory
CeTTs

Host Resistance to Cha11enge With:
Bacteria Viruses Protozoa Nematode Tumor CeTTE'

Reference

T

T

T

+

T

-

2,3,7,8 Tetrach10rodibenzo-

T

T/NE

NE*

T

T

-

HexachIorobenzene

NE

NE

t/T

NE

T

PolychTOrinated biphenyT (PCB)

T

i

T

-

-

T

PoTybrominated biphenyT (PBB)

NE

T

T

NE

NE

-

Lead

T

T

NE

T/NE

T

T

-

46,47

Cadmium

-

T

+/T

i/T

T

T

T

48

p-dioxin (TCDD)
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T

decreased

+ - increased
T/+

confiicting reports or ce11 subpopuIation differences

NE - not effected

-

T

T

T

34,35

-

T

36,37

T

T

38,39,40

T

39,41,42,43

T

-

44,45

dysfunction has been adequately demonstrated in laboratory animals exposed to
environmental contaminants, especially when exposure occurs during development
and maturation of the immune system.
Whether or not these laboratory results

can be interpreted as indicative of possible effects following human exposure
s
is unknown since many laboratory studes have utilized dosage levels and
exposure routes that are unlikely, at best, to occur during human occupational

or environmental exposure.
Nonetheless, alteration of the human immune system
has been demonstrated after chemical exposure and the results of immunoas
says

were similar to those obtained in animal studies (e.g. see 44,45,49,50).

Occupational exposure to certain chemical

compounds (e.g. benzene) has been

associated with the development of human malignancy (51) and in animal models,
with immunosuppression (52).
The medical profession has been aware of the potential sequelae which
may
follow immunosuppressive drug therapy and therefore monitor patients receivin
g
such treatment closely to detect infection or cancer development.
Since the

therapeutic goal in these patients is to significantly reduce the immune

response, usually for a relatively short time, levels of drug administ
ration
are high and effects on the immune system are marked.
However, exposure to

potential environmental immunotoxicants will likely be at levels which produce
immune effects with chronic exposure.

Therefore,

adequate test systems for

low level chemical exposure need to be developed and validated so that their
results may be rationally extrapolated to the human population. While all
chemical products should not be considered for screening, those that are

likely to be found in the workplace or in food, water, or other preparations
for ultimate human consumption should receive at least basic evaluati
on to
determine immunotoxicity.
Immunotoxicologic evaluation of their products is
at present a routine procedure for about one half of the pharmaceutical

industry (53).

This approach, while providing needed safety assessment, may

also provide experimental

insight into immune function, disease, disease

susceptibility and resistance to neoplasia.

5.5 RECOMMENDATIONS
l.

Adequate test systems need to be developed to measure the effects on the
immune system resulting from low level, chronic exposure to chemicals.

2.

All chemical products do not need to be tested for immunotoxicity.
However, at least basic evaluation for potential effects on the immune
system should be carried out on those chemicals for which there will be

significant human exposure.
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6. Summary: Roundtable on Data Requirements from
Surveillance and Monitoring Programs

6.]

INTRODUCTION

Surveillance and monitoring programs of contaminants in fish
and water

provide large amounts of data annually for a variety of purposes; however, the

type, quantity and quality of the data have not always been
adequate for

assessing the impact of these contaminants on human health.

The Committee on

the Assessment of Human Health Effects of Great Lakes Water Quality
emphasized
in its l98l Report the need to consider the specific data required from these
programs to evaluate health impact.
A Roundtable was convened on March l7 l8, l982, to address this
topic and
resulted in the preparation of the proceedings of the "Roundtable on
The

Surveillance and Monitoring Requirements for Assessing Human Health Hazards
Posed by Contaminants in the Great Lakes Basin Ecosystem".

To reduce

ambiguity, surveillance was defined as: "the repeated measurement of a
variable in order that a trend may be established . Monitoring was defined
as: "the measurement of a fixed variable chosen to provide data on how well
regulations are working and how far standards are being met."
Surveillance was deemed to include annual quantitation of well known,
"old" contaminants and the identification of previously undetected,
"new" contaminants. Monitoring was considered in terms of compliance

11.' .e.,
.e.,
( e.g.

the determination of levels of contaminants for which guidelines or

standards have been established) in commercial and sport fish or finished

drinking water.

Although the scope of this Roundtable was limited to a consideration of

programs pertaining to chemical contaminants in fish and water and to

microbiological contaminants in water, Roundtable participants emphasized the
need for data on contaminants present in air and in food. Comprehensive human
health impact assessments must consider the total exposure.

6.2 EXISTING SURVEILLANCE AND MONITORING PROGRAMS.

Extensive surveillance and monitoring programs exist or have been proposed

through a variety of federal, state, provincial or international agencies with
jurisdictions on or surrounding the Great Lakes. The development of these

programs has been closely tied to the Great Lakes International Surveillance
Plan (GLISP), a detailed document prepared by the International Joint
Commission as required by the l978 Water Quality Agreement between the United
States and Canada. In general, programs have been redesigned to meet changing
requirements; however, current fiscal restraint has dramatically reduced the

depth and utility of some programs and prevented the implementation of others.
Summaries of surveillance and monitoring programs of the jurisdictions are
presented in the proceedings.
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6.3 GENERAL THEMES

Several recurrent themes surfaced during the Roundtable deliberations
and
later during the preparation of the proceedings. These are noted below.
0

Chemical Surveillance.
Unlike compliance monitoring, which serves
the mandate of each specific jurisdiction, surveillance is required

to serve a more general need. Surveillance must meet the needs of
the future, through establishing trends in chemical concentration and

by identifying emerging problems.

surveillance programs.

Compliance monitoring.

More emphasis must be placed on

Generally adequate compliance monitoring of

fish and water exists in the basin; programs conducted by New York
State and the Province of Ontario are especially comprehensive.

Interagency cooperation and coordination. More discussion among the
jurisdictions of program objectives and logistics is warranted.
Coordination of sampling, analytical and assessment methodologies

could be increased.

Benefits would include implementation of more

effective and comprehensive programs and sharing of research loads.
This theme is especially relevant to surveillance programs.
Comparability of data.

A major flaw with existing programs stems

fran the lack of comparability of data collected by individual

agencies. While the sampling network provides extensive coverage of
the Great Lakes Basin, differences in time of sample collect
ion,
variation in portions of fish analysed, non-standardized present
ation
of data and inadequate quality assurance prevent the development
of a

clear picture of contaminant levels and trends thoughout the basin.
Comparability of data is especially critical for surveillance
programs.
Data reporting.

Summary reports of surveillance data collected from

fish and water sampling programs are rarely exchanged on a routine

basis between jurisdictions.
Clearly formated data with details of
their origin are urgently needed annually and especially by
the
Health Effects Committee of the International Joint Commis
sion.
The
special need for better reporting of waterborne disease outbreaks
is

also emphasized at the Roundtable.

Objectives of health hazard assessments.

Two distinct approaches to

health assessment emerge, each based on a different program
objective. Some agencies require prediction of toxic levels of
contaminants in order to issue consumption guidelines to the
public
for fish and water and to analyze fish and water for compliance with
these levels. Other agencies assess the current health impact
or

estimate the health risk for populations using data on existin
g
contaminant levels in fish and water and consumption patter
ns.
Both
objectives are valid; however, the second objective, requires the

collection of more detailed consumption figures before it can be
used
to identify populations or sub-populations at risk.

0

Basic research and evaluation.
The need for a vibrant basic research
program was frequently emphasized.
Furthermore, an annual meeting at
the scientific level was recommended in order that the results of

research and surveillance programs coulo be adequately evaluated and
decisions made on the need for change and new directions.

0

Agreement on intervention levels. Public confidence would be
considerably enhanced if the jurisdictions accepted common guidelines
or invention levels for contaminants in fish and water. A stumbling
block to such progress still seems to be the uncertainty over
contaminant interactions in the environment.

6.4 SPECIFIC DATA REQUIREMENTS
The specific data required of surveillance and monitoring programs that
will enable more adequate health assessment to be conducted and the conditions

for its generation, were considered in detail at the Roundtable.

These

specific requirements for data from programs that sample chemical contaminants
in fish and water and microbial contaminants in water are too numerous to
summarize here; hence, they have been provided in Appendix l of this report.

6.5 FUTURE CONSIDERATIONS
Several topics related to the specific objectives of the Roundtable
require future consideration:

0

comprehensive health impact assessments can only be conducted when
adequate data from food and air monitoring programs become
available. The data required from fooo and air surveillance programs
must be carefully considered;

0

access to up-to-date industrial production and use data would be
extremely useful in assessing the potential for human exposure to

chemicals. Furthermore, the identification of a central clearing
house for information of this type for the heavily industrialized
Great Lakes Basin should be considered;
0

the usefulness of the surveillance of contaminant levels in human

tissues requires evaluation.

The benefits for prioritization of

research are likely to be significant; however, implementation of
such programs requires the cooperation of the public, professional
groups and the jurisdictions; and

0

future consideration must be given to the design and implementation
of sensitive epidemiological surveys (eg. case control studies and
cohort studies) to determine the impact on human health and
reproduction of exposure to contaminants in the Great Lakes Basin.

6.6 CONCLUSIONS

Consideration of public health impact as a rationale for sampling fish and
water does not imply that existing surveillance and monitoring programs be
changed. Rather, it implies re-evaluation of existing programs designed, in
part, to provide data suitable for health hazard evaluation. The specific
requirements detailed in the proceedings of the Roundtable provided in

Appendix 1 of this report are the basis for such a re-evaluation.
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Development of surveillance data on those
chemicals listed in Table 7.3 of
the Committee's 1982 Report and selected
chemicals in Table 7.5 (see Chapter
7) will be extremely useful to agencies invol
ved in the assessment of the
impact on human health of contaminants
in the Great Lakes basin.

6.7 RECOMMENDATIONS
General

It is recommended that the jurisdiction
s of the Great Lakes Basin:

l.

recognize the need to assess the chronic healt
h implications and
impact

on reproduction of low level exposure of
residents of the
Great Lakes Basin to environmental chemicals;

increase the comparability of their data
by:
(a) more frequent interagency communication
and review of sampling,
analytical and assessment methodologie
s; and
(b)
implementing quality assurance programs;

(a)

report to the IJC at least annually the findi
ngs of surveillance
and monitoring programs on the Great Lakes and
provide complete

details of sample collection, handling
and analysis; and

(b)

meet annually to discuss the significance of the
data
forthcoming from surveillance and monitoring progr
ams and to
propo

se changes in future programs as deemed scien
tifically
appropriate.

evaluate their surveillance and monitori
ng programs that provide data
pertaining to public health, in terms
of the specific requirements
listed in the proceedings of the Roundtab
le and alter their programs
as required.

Surveillance and Monitoring of Fish and
Water for Organic and Inorganic
Chemicals:
It is recommended that the jurisdic
tions of the Great Lakes Basin:

5.

consider immediately surveillance for thos
e chemicals iden

tified by
the Committee on the Assessment of Huma
n Health Effects in Table 7.3
of its 1982 Report but not to the excl
usion of those listed in Table
7.5 of the l982 Report;
address the issue of the human health impa
ct of chemicals in drinking

water;

.

a)

conduct compliance monitoring programs
of commercial and sport
fish species caught for consumption; and

b)

augment surveillance programs for the
identification of new
chemicals and the determination of trend
s of "old" chemicals;

continue to gather data on the fish
consumption patterns of

Great
Lakes Basin residents in order that monitoring progr
ams can be
tailored to meet consumption patterns and
health risk assessments be
based on sound
exposure figures; and
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9.

resolve the "edible portion" issue by:

a)

b)

agreeing on a standard edible port
ion; or

conducting research on the relationships betw
een differen

t
portions of different species of fish
such that data from
different jurisdictions can be compared.

Surveillance and Monitoring for Microbiologi
cal Contaminants in Water
It is recommended that the jurisdiction
s of the Great Lakes Basin:
l0.

a)
b)

ll.

investigate the hazard to health of bathing
waters by:
a)
b)
c)

improve their reporting of waterborne disea
se outbreaks; and
monitor, more frequently, effluent disc
harges in areas where
waterborne disease outbreaks have occurred;

ensuring that current monitoring programs for
bathing waters are
utilizing the best indicators of contaminatio
n;
gathering data on those organisms identified as poten
tially
useful indicators of microbiological contaminat
ion of water; and
conducting
research on the role between the microbiological

quality of bathing water sediments and the trans
mission of
disease to bathers.
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7. Update of Tables of Great Lakes Chemicals Published
in the Committee's 1981 Annual Report
7.l

INTRODUCTION

The Human Health Effects Committee published five tables in its l98l

Report that categorized those chemicals listed in Appendix E of the l978
Great

Lakes Water Quality Board Report by their acute and chronic hazard
to man.
The hazard evaluations conducted and reported by the Committee pertain
ed
exclusively to the presence of these chemicals in the Great
Lakes Basin and

their potential to impact on human health.

'__

The Committee concluded that the evaluations that led to Tables
l through
5 of the l98l Report should not be construed as final; changes would
be
required as new data on the toxicity of these chemicals, their use and
levels
in the Great Lakes Basin ecosystem became available.

The Committee also considered the reported concentration of the chemical

in the ecosystem.
Consequently, for example, because of its properties, a
given chemical may be hazardous to human health under certain exposur
e
situations, but, because of the concentration at which it is present in the
Great Lakes ecosystem, the potential for exposure via this pathway may
be
minimal.
The chemical may, therefore not represent a hazard to human health

under present circumstances in the Great Lakes Basin ecosystem and would

therefore be of minimal concern for such purposes as conducting Great Lakes

surveillance and monitoring activities.

It should be recognized, however,

that some environmental impacts can occur at levels far below those deemed
critical for human health concerns and surveillance and monitoring may
be

desirable, based on other considerations.

For 1982, the Committee has updated last year's tables based on the
constructive suggestions of many reviewers. The five basic tables remain and
the rationale for each is reiterated below. The re-evaluation involved
several aspects, including:
o

the Committee cross-checked within and between tables for double

listings and the accuracy of chemical names.

In numerous cases

chemicals in appendix E were listed twice under different names or

the CAS number did not match the chemical;
o

the Committee re evaluated some chemicals in Table 5 for which there
were new toxicity data or reports of levels in the environment;

0

the Committee grouped all chemicals listed in Tables 2 through 5 into
chemical classes. In this way, chemicals of the same class but in

different tables could be readily observed.
In addition, certain
classes of compounds emerged about which the Committee felt they
could make recommendations.

It should be noted that the findings by the Health Effects Committee do
not in any way conflict with a jurisdiction's regulatory strategy for a
chemical which it considers to be hazardous to human health.
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7.2 RESULTS OF UPDATING
Updated versions of the original five l98l tables are provided in this

chapter (Tables 7.l through 7.5). Minor changes in title reflect the
Committee's desire to reduce any ambiguity in the titles of last year's tables
and not a shift in the original rationale any of the tables. Descriptions of
the updated tables follow. The specific changes made in each table are
described below and in more detail

in Appendix 2.

Table 7.l.
This table lists those chemicals that have been reported in the Great
Lakes Basin ecosystem which have the potential to impact on human health based
on their relatively high acute toxicity for mammals.
High levels of these

contaminants (resulting from spills, industrial discharges or excessive run

off) in local areas, such as water intake zones, recreational water sites or
underground water reservoirs, could be hazardous to human health.

There are only two significant changes in Table 7.l between the l98l and
l982 reports; dichloropropane has been deleted because its acute oral LD50
in the rat exceeds 500 mg/kg and kepone has been deleted because it has not
been found in the Great Lakes Basin. Minor changes in the chemical names have
also been made.
Chemical Abstracts Service Registry (CAS) numbers are not
provided because all Table 7.1 chemicals appear in one of the following four

tables and are listed with their CAS numbers there. Chemicals have not been
grouped into classes because the grouping by toxicity is more useful.

It is necessary to emphasize that some chemicals listed in Tables 7.4 and
7.5 may also be highly acutely toxic; however, there are insufficient data to

assess their acute toxicity at this time.

Furthermore, some chemicals not

originally identified in Appendix E of the l978 Great Lakes Water Quality
Board Report, but present in the basin, may be highly acutely toxic.

Table 7.2.
This table lists those chemicals found in the Great Lakes Basin ecosystem

that are known to have long term toxic effects in mammals and that are
currently subjected to regulatory monitoring for health reasons.

Phenols and

inorganic chemicals such as iron, copper and manganese have not been listed
despite the fact that there are drinking water guidelines in existence. These

guidelines are based on aesthetic considerations of taste, colour or odour,
but not toxicity.
Nickel does not appear in Table 7.2 for similar reasons.
Nickel should be considered for surveillance, based on its potential health
impact; however, the current water quality objective provided by the
International Joint Commission is based upon fish toxicity.
Nickel appears in
Table 7.3.

Only minor changes have been made in the content of Table 7.2; however,

the format has been altered.
All chemicals have been grouped by classes.
This arrangement of chemicals makes clear the emphasis placed on the setting
of health guidelines for two groups, pesticides and elemental contaminants.

Table 7.2 also identifies the types of monitoring guidelines or standards in
effect or proposed for each chemical and the CAS number.

Minor changes

include the grouping of chloroform and other trihalomethanes under one
heading, the addition of photomirex (a degradation product of mirex) and small
changes in chemical names.
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TABLE 7.1.
CHEMICALS FOUND IN THE GREAT LAKES WHICH MAY IMPACT
ON HUMAh HEALTH IN THE EVENT OF
HIGH LOCAL CONTAMINATION*
Extremely toxic chemicals (L050 <50 mg/kg)
Aldrin
Carbofuran

Dieldrin
2,3,7,8 Tetrachl0rodibenzodioxin (2,3,7,8,-TCDD)
Endosulfan
Endrin

Ethion

Methyl mercury (chloride)
Oxychlordane
Toxaphene

1,1,2 Trichloro

1,2,2-trifluoroethane

Very toxic chemicals (LDso 50 500 mg oral/kg)
Aniline
Bromochloroethane
Carbon disulphide
Chlordane
2-Chloroaniline
4 Chloroaniline
o Cresol
DDT
Diazinon
1,2-Dibromoethane
1,2-Dichlorobenzene
2,3-Dichlorobutadiene

2,4-Dichlorophenoxyacetic acid (2,4 D)
1,3 Dichloropropene
2,3-Dichloropropene
Diphenylamine
N-Ethylaniline
Furfural
u Hexachlorocyclohexane
y Hexachlorocyclocyclohexane (Lindane)
Hexachlorobutadiene
Mirex
Pentachlorophenol
Phenol
Photomirex
Tetrachloroethane**
1,1,2,3-Tetrachloropropene
2,4,5 Trichlorophenoxyacetic acid (2,4,5-T)
Vinyl Bromide
Vinyl Chloride
Elements which form toxic compounds (LDso <500 mg oral/kg.)

Arsenic

(trioxide3+l

Cobalt
Lead
Mercury
Nickel
Silver
Vanadium

(cobaltou52+)
(alkyl4+)
(elementalol
(acetate2+)
(nitrate3+)
(trioxide3+)

Cadmium

(chloride)

* Based on acute oral exposure in rats. Principal data base:
NIOSH Registry of Toxic Effects of Chemical Substances, 1979, USHHS.

** Unspecified isomer(s)
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TABLE 7.2
CHEMICALS FOUND IN THE GREAT LAKES WITH KNOWN EFFECTS IN MAMMALS
THAT ARE CURRENTLY SUBJECTED TO REGULATORY MONITORING*
CHEMICAL NAME

CAS NO.

MONITORING PROCRAM**

PESTICIDES
ATdrin
ChTordane (totaT isomers)
2,4-DichTorophenoxyacetic acid(2,4-D)
DDT (DDE, 72-55-9 and DDD, 75-54-8)

309 00 2
57-74 9
94-75-7
50 29 3

DN
DN
DN
DN

Dierrin

60 57-1

DN

HeptachTor
HeptachTor epoxide

76-44-8
1024-57-3

Dw
DN

72-43-5

DN

Diazinon

Endrin

333 41-5

72-20 8

Lindane (y-hexachTorocycTohexane)

58-89-9

Mirex (and photomirex, 39801-14-4)

2385-85 5

MethoxychTor

Silvex
Toxaphene

DN

DN

F
F

NQO
NQO

F

NQO

F

F

Dw

93-72-1
8001 35 2

DN
DN

1336-36 3
67-66-03

DN

NQO

NQO

NQO
NQO

NQO

NQO

F

NQO

F

NQO

F

NQO

F

NQO

HALOGENATED HYDROCARBONS
PoTychTorinated biphenyTs
TrihaTomethane (chToroform)

(bromoform)
(bromodichToromethane)

75 25-2
75 27-4

(iododichToromethane)

594 04-7

(chTorodibromomethane)

124-48-1

ELEMENTS
Arsenic

7440-38-2

DN

Chromium

7440-47 3

DN

Cadium

7440 43-9

Lead

Mercury (methyT)
SeTenium
SiTver

7439-92-1

115-09-3

7782 49-2
7440-22-4

DN

DN

Dw

NQO

NQO

F

DN

NQO

NQO

NQO

WOO-P
NQO-P

ETHERS
2,3,7,8-TetrachTorodibenzodioxin

1746 01-6

F

* Monitoring based on concern for human heaTth.

**

DN
F

WOO
NQO-P

United States or Canadian drinking water guideTine or standard
- GuideTine for acceptabTe TeveTs in fish (heaTth protection)

- Nater QuaTity Objective in Annex 1 of the 1978 Great Lakes Nater

QuaTity Agreement

- Water QuaTity Objective proposed by the Aquatic Ecosystems Objectives
Committee, IJC Science Advisory Board
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Table 7.3.

Chemicals found in the Great Lakes Basin ecosystem that have the potential
to impact on human health because of known long-term toxic effects on mammals

and their use, release or appearance in the basin, are listed in Table 7.3.
The Committee recommends that these compounds be considered for inclusion in
surveillance programs; the type of surveillance recommended by the Committee

is provided in this year's table.

Changes to Table 7.3 include the addition of several chemicals (benzo (b)-

and benzo (j) fluoranthene, cresol, l,2 dichloroethylene, and endosulfan) the

grouping of all chemicals by class and minor changes to headings and chemical

names.
Summary evaluations and the bases for surveillance for most chemicals
are provided in the Committee's l98l report and are not reproduced here.
Summary evaluations for chemicals added this year are provided in Appendix 3.

Data forthcoming from surveillance programs that have attempted to

identify and quantify these chemicals must be carefully evaluated.

Continued

surveillance may not be warranted if levels are exceedingly low, declining, or
if industrial use patterns indicate declining consumption.
Table 7.4.
Table 7.4 lists those chemicals found in the Great Lakes Basin ecosystem
that are of minimal current concern from the human health perspective. This

assessment is based on an evaluation of all existing data on toxicity use and

environmental levels.
There are numerous additions and corrections made to
Table 7.4 as a result of a careful auditing exercise that identified several
multiple listings of the same chemical by different names and a re evaluation

of Table 7.5 compounds.

The specific changes and the rationale for the

changes are presented in Appendix 2 of this report.

For consistency, Table

7.4 has also been organized into chemical classes and CAS numbers have been
added.

Table 7.5.

Those chemicals found in the Great Lakes Basin ecosystem for which there

are insufficient data to conduct a health hazard assessment, are listed in
Table 7.5.
The chemicals listed have either insufficient toxicity data or too
few details of their use, release or levels in the basin. Some of these
chemicals may prove to be toxic to mammals in future studies.
Partial reconsideration of the chemicals listed in Table 5 of the l98l
Report has resulted in a large number of deletions. Some chemicals were

previously listed in other tables by different names, others have been
re-evaluated using new data and moved to other tables. The changes and
accompanying rationale are given in Appendix 2.
several compounds appear in Appendix 2.

Summary evaluations for

Chemicals appearing in Table 7.5 should not be excluded from consideration

for surveillance. Determination of the levels of these chemicals in the Great
Lakes Basin ecosystem would aid the assessment process greatly. Research
efforts should be directed toward compounds in Table 7.5 which have or are
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likely to have significant long term toxic effects on mammals.

The pesticides

listed have well defined toxic properties; however, their levels in the
environment are poorly documented.
The toxic properties and the environmental
distribution of the chemicals in the halogenated hydrocarbon group, the
aromatic hydrocarbons and the ethers are poorly characterized.
Some groups of chemicals in Table 7.5 are of low priority for further

research and data gathering.

Terpenes are naturally occurring organic

chemicals in plants that are likely to be ubiquitous.

Little is known of

their specific toxicology or their levels in drinking water and fish.

Although there are currently insufficient exposure and toxicity data to move

the terpenes into Table 7.4, they should be considered a low priority for

further work.
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TABLE 7.3

CHEMICALS FOUND IN THE GREAT LAKES WITH THE POTENTIAL TO IMPACT ON
HEALTH THAT ARE NOT CURRENTLY SUBJECT TO REGULATORY MONITORINC
BUT FOR WHICH SURVEILLANCE SHOULD BE CONSIDERED* ~1982
SURVEILLANCE RECOli JilENDEDH

CHEMICAL NAME

CA5 N0.

HATER

FISH

AIR

PESTICIDES

Endosulfan (thiosulfan)
Hexachlorobenzene
Oxychlordane+
Pentachlorophenol

2,4,5 Trichlorophenoxy acetic
acid (2,4,5 T)

115-29-7
118-74 1
26880 48-8

NS

NL
NL
NL

93-76 5

NS

NL

50 23 5

ID;NS

ML

87-86-5

NS
NS

WL;NS

HALOGENATED HYDROCARBONS
Carbon tetrachlcride
1,2-Dichloroethane
1,2-Dibromoethane

Hexachloroethane
1,2-Dichloroethylene
Trichloroethylene
Tetrachlorocthylene
Vinyl chloride
Vinyl bromide
3 Chloro-I propene
2,3-Dichlorobutadiene

Hexachlorobutadiene
Dichlorobenzene (1,2 )
(1,3-)
(I,4-)
a-Hexachlorocyclohexane
Chlorinated naphthalenes
Brominated biphenyls
Chlorinated terphenyls

107-06-2
106v93 4

67-72-1
540-59-0
79 01 6
127-18-4
75 01-4
593 60 2
107 05-1

1653~19-6

87 68 3
SS SO I
541 73 1
106-46-1
319-84-6

ID;NS

NL
NL

A
A

NL
NL
NL
NL

A
A

NS
ID;NS
NS
ID
ID
ID
ID

NL

ID;NS

NL

NS
NS
NS

NL
NL
NL
NL

NS
NS

NL
NL

ARDMATIC HYDROCARBONS
Ethylbenzene
Styrene
Benzo(a)pyrene
Chrysene
Dibenz(a,h)anthracene

100 41 4
100-42-5
50 32-8
218-01-9
53-70-3

NS
NS
NS
NS
NS

HL
ML
NL
NL

Benzo(J)fluoranthene

205-82 3

NS

HL

Benzo(b)fluoranthene

205 99-2

NS

HL

A
A
A

A

A

PHENOLS
Cresol+ (o,m,p)
Trichlorophenol+ (2,4,5-)
(2,4.6-)

l319 77 3
95-95 4
88-06-2

ID,NS
NS

NL

l23-9l-l

ID;NS

NL;NS

ETHERS
Dioxane
ACIDS AND ESTERS
Phthalic acid, aiisobutyl ester
Phthalic acid, di(2-ethylhexyl)
ester

84-69-5

NL

ll7-8l-7

HL

MISCELLANEOUS
Aniline
Azobenzene
3,3' Dichlorobenzidine

62-53 3
l03-33-3
9l-94-l

ID
ID
ID

7440 02-0

ID

ELEMENTS
Nickel
*

A,ID

Potential to impact on health' based on all available data on toxicity.
use and environmental levels.

** ID
industrial discharges
NL - Hhole lake
NS - Near shore
A - Ambient
+

covered under

parent compound in some jurisdictional guidelines.
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TABLE 7.4
CHEMICALS FOUND IN THE GREAT LAKES 0F MINIMAL CURRENT
LONCERN FROM A HUMAN HEALTH PERSPECTIVE

CHEMICAL NAME

CAS N0.

CHEMICAL NAME

PESTICIDES

CA5 NO.

ALDEHYDES

Atrazine
Carbofuran
Biomba
Ethion
Leptophos
Malathion
MCPA (4-chloro-o-toloxy acetic acid)

1912-24-9
1562 66-0
1918 00-9
563 12-2
21609-90-5
121-75-5
94 74-6

Formaldehyde
Vanillin
KETONES
Acetone
Z-Butanone

106-97-8

Butane (1-)

(2-)

106-98-9

ETHERS

106-99 0
689 97-4
109-66-0

Diethyl ether
Diisopropyl ether
Safrole

107-01-7

1,3-Butadiene
1-Buten~3-yne
Pentane

Neopentane
Cyclopentane

Pentene (1-)
Hexane
Cyclohexane
Heptene

ACIDS AND ESTERS

Methacrylic acid, methyl ester
2-Methylpentanoic acid
Hexanoic acid (Caproic acid)
Hexanedioic acid. dimethyl

25264-93-1

Nonene

60-29 7
108 20-3
94 59-7

109-684
110 54-3
110-82-7

25339-564

Hexene

96 22-0
98 86-2
108-10 1

463-82-1
287-92-3

109-57-1

(2-)

67-64-1
78 93-3

3-Pentanone
Acetophenone
4-Methyl-2-pentanone

ALIPHATIC HYDROCARBONS
Butane

50 00 0
121-33 5

(Diniethyl adipate)

27215-95 8

Hexanedioic acid, dihexyl

80-62-6
97-614)
1412-62-1

ester

627 93-0

ester

2,5-Dimethyldecane
2,6-Diuiethylundecane
Tetradecane

17312-50-4
17301 23-4
629-59-4

(Dihexyl adipate)
Heptanoic acid (Enanthic acid)
Octanoic acid (Caprylic acid)

110-33-8
111-14-8
124-07 2

Hexadecane
Decylcyclohexane
Heptadecane

544-76-3
1795-16-0
629-78-7

Nonanoic acid (Pelargonic acid)
Decanoic acid (Capric acid)
Dodecanoic acid (Lauric acid)

112-05-0
334-48-5
1433-07 7

Tetracosane

646-31-1

(Methyl laurate)
Tetradecanoic acid (Myristic acid)

111-82-0
544-63 8

(Methyl myristate)
Pentadecanoic acid
Hexadecanoic acid, methyl ester
(Methyl palmitate)
Hexadecanoic acid, ethyi ester
{any} pa mitate)

124-10-7
1002 84-2

523-974

9-Hexadecanoic acid (Palmitoleic acid)
Heptadecanoic acid (Margaric acid)

2091-29-4
506-12-7

Tetradecene

1120-36-1

lO-Methyleicosane

Z Ethylhexanoic acid, methyl ester

55193-56 1

Dodecanoic acid, methyl ester

HALOGENATED HYDROCARBONS

Dichloromethane
Dichlorodifluoromethane
Trichlorofluormethane
Dichlorobromofluorwethane
1,1,l-lrichloroethane

1aliz-TT ICMOTO-l iz-tr)fluoroethane

Tetradecanoic acid, methyl ester

75-09-2
75 7l-8
75-69-4
353-58-2
71-55-6

76'13-1

Benzene

(Methyl stearate)

9,10-Dihydroxyoctadecanoic acid, methyl ester

95-47-6
108-35-3

(9 )

9-0ctadecenoic acid (cis)(Oleic acid)
9~0ctadecenoic acid, methyl ester (trans)

106-42'3

Propylbenzene

(Methyl elaidate)

103-65-1

CW"!

98-82'8

Propyltoluene
Diethylbenzene
Naphthalem

l,2-Dihydro-6-Iuethylnaphthalene

Biphenyl
Di-ethylbiphenyl

kenlphthe e

2717-47-7

"G Mlin hraCE'Ie (1')

510-43'0

(9-)

779-02-2

(2-)

60 33 3
301-00-8
7217-83 6
506-30-9

(Methyl arachidate)
Docosanoic acid (Behenic acid)

Tetracosanoic acid (Lignoceric acid)

101-81-5
86-73-7
120-12-7

Benzoic acid
Salicylic acid
Phthalic acid, dibutyl ester

Phthalic acid, butyl ester, ester with

613-12-7

butylglycolate

Phenanthrene
Hethylphenanthrene
HUOWNMM

85-01-8
28652-81 5
206 44'0

Benzofluorene (l,2 )

238~84-6

Phenol

56 55-3
207-08 9

Borneo]

Pyrene

(2,34

Benzanthrene
Benzo(k)fluoranthene

Per ene

Coronene
Dibenzo(def,mno)chrysene

(2-)

tert-Butanol
Z-Buten-l-ol

Z Ethyl-l-hexanol

1-Decanol
Tetradecanol
l-Octadecanol
l-Dodecanol

Benzyl alcohol

1120-28-1
112-85-6

557-59-5

65-85-0
69-72-7
84-74-2
85-70-1

pHENoLs
Guaiacol (methoxyphenol)

129-00-0

243-17-4

90-05-1

108-95-2

TERPENES

193-55'0

Camphene

191-07-1
191-26-4

50740-0

79-92-5

Camphor
[sobomeoi
Limonene

46449-3
12445-5
138-86-3

71-23-8

Pinene (a-)
(5.)

80 56-8
12741.33

75-65-0
6117-91-5

Temineo]

3000_41_7

104-76-7

MISCELLANEOUS

ALCOHOLS

Propanol (1 )

112-80-1
1937-62-8

(Methyl linolenate)
Z-Methyloctadecanoic acid
Eicosanoic acid (Arachidic acid)
commit acid, Methyl ester

92-52-4
28013 11-8

112-6143

1115 01-1

9,12-0ctadecadienoic acid (Linoleic acid)

9,12,15-0ctadecatrienoic acid, methyl ester

28729-54-6
25340-17-4
91'20'3
83-32'9

Diphenylmethane
Fluorene
Anthracene

57 10-3

Octadecanoic acid, methyl ester

71-43-2

108-88'3

XYlene (0-)
(l')

112 39-0

Hexadecanoic acid (Palmitic acid)

AROMATIC HYDROCARBONS
TOWERS

816-19-3

67-63 0

112-30-1
27196-00-5
112-92-5
112 53 8

Benzothiazole
Caffeine
Carbon disulfide

100-51-6

N,N-Dimethylaniline

95-16-9
58-08-2
75-15-0

121 69-7

ELEMENTS
Cobalt

Copper
Strontium
Vanadium
Zinc
*
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Based on all available data on toxicity,

7440-48-4

7440-50-8
7440-24-6
7440 62-2
7440-66 6
use and environmental levels.

TABLE 7.5.
ChEMICALS FOLND IN THE GREAT LAKES FOR HHICH THERE ARE INSUFFILIENT
DATA AVAILABLE TO CONDUCT A HEALTH HAZARD ASSESSMENT"

ChEMCAL NAME

CAS NO,

CHEMLAL NAME

PESTICIDES

CA5 N0.

ETHERS

Alachlor
Chloropyrifas
Cyprazine
Ethuron

15972-60-8
2921-88-2

Dimethoxymethane
Bis(2-chloroethyl) ether

759-94-4
21087-64-9

Trietlu'leneglycolethyl ether
4 Bromoanisole

22936-86-3
15545-50 3

EPTC (Eptan)
Metribuzin
Nonachlor
Prometone
Simazine

3734 49-4
1610 18-0
122-34-9

Trifluralin
DMPA (Zytrun)

Pentachloroethane
Trichloropropane (1,1.2-i
(1.2,2-)
Pentachloropentane (l,1,2,3,3 )

(1.1.1,2,3-)

(1,1,1,3,3-)

Dichloro l-propene

Tetrachloroprcpene (1,3,3,3-)
(2,3,3.3-)
(l,l,3.3-)

(1,2,3,3 )

112-50-5
104-92-7

54518-15-9
6130-75 2
87-40 1

a,q,1,4,5-Pentachloroanisole
Dichloromethoxyphenol
2,4,6 Trichloro 3-methoxyphenol

33104-17-5
.....

26378 18 7

4-Ch'loro-1,2-dimethoxybenzene
1,2-DichlOrzo 4,5-dimethoxybenzene
1,2,3-Trichloro 4,S-dimethoxybenzene

16766-27 1
2772-46-5
16766 29 3

2,4,6-Tribromoanisole
Tetrachloroanisole

HALOGENATED HYDROCARBONS

Ethyl chloride
l-Bromo-Zvchloroethane
Dibromochloroethane

108-60-1
629 14 1

Dichloroanisole
Trichloroanisole (2,4,5-)
(2,4,6 )

1582-09-8
299-85-4

lermOmEthane

109-87 5
111-44-4

Bis(2-chloroisopropyl) ether
1,2-Diethoxyethane

74-95-3

607 99-8
53452 81 6

2,3,4,5-Tetrachloro-G-methoxypl.enol

75 00 3
107 04 0
73506-944

76 01-7
598-77-6
3175-23 3
15104-614

2539 17-5

Z Methoxy-Il-propylphenol
4-Methyi 2 ethy1-1,3-dioxoiane
Dehyarodiconiferyl alcohol
Tetrahydrofuran

21700-31-2

2785-87-7
4359-46-0
4263-87-0
109-99-9

Methyltetrahydrofuran

25265-68-3

23153-23 3

Tetrahydropyran

15022-22-7
16500-91 7
18611-43-3

ACXDS AND ESTERS
_
Phenylacetic acid

30353-54-9
18766 87 5
921-09-5

(3-)
2-(4-Chlorophenoxy)-2-methylpropanoic acid
2 (4 Chlorophenoxy)butanoic acid, methyl ester

26952 23 8

20589 85 9
26761-81-9

142-68 7

103-82-2

4-Hydroxy 3-methoxyphenylacetic acid
Phenylpropanoic acid (2-)

306-08-1
492-37-5

1637 31-6
18149-76 3

Phthalic acid, dimethyl ester
Phthalic acid, diethyl ester

131-11-3
84-66-2

21400-41-9
319-85-7
108-86-1
108-90-7
87-61 6
120-82-1

Phthalic acid, dioctyl ester

117-84-0

PHENOLS
_
Chlorophenol (2-)
-

95-57-8
108-43-0

634-90-2

Dichlorophenol (2,3-)

576-24-9

Chlorotoluene (2-)
(3-)
(4-)
Tetrachlorotoluene (a,a,u,2 )
u,a,u,4-)
(u,a,2,4-)

95-49-8
108-41-8
106-43-4
2136-89-2
5216-25-1
134 25-8

(2.6-)
(4,6-)
2,3,4,6-Tetrachlorophenol
o-Phenylphenol
tert-Butylpyrocatechol

87-65-0
120-83-2
58-90-2
90-43-7
27213-784

(u,2,3,6-)

1424-79-9

Dichlorobutane

1,1,4,4,4-Pentachloro l-butene
1,1,1,4,4,4-Hexachloro-Z-butene (trans)
Tetrachlorobutadiene (1,1,2,3 )

(l.1,3,4-)
(l,2,3,4-)

Pentachlorobutadiene (l.l,2,3,4-)

(l,1,2,4,4-)
s Hexachlorocyclohexane
Bromobenzene
Chlorobenzene
Trichlorobenzene (l,2,3 )
(1,2,4-l
Tetrachlorobenzene (1,2,3,4-)
Pentachlorobenzene

(1,2,3,5-)

(a,u,2.6-)

Pentachlorotoluene

5659-44 9

634 66-2

29082-75-5
25283-02 7

Terpinene

1 1sopropyl-4-methyltenzene
Butylbenzene (n-l
(sec-)

99-87-6
104-51-8
135 98 8

l-Isopropyl-3-methylbenzene

(tart-i
Methylnaphthalene

Dimethylnaphthalene
l-Phenylnaphthalene
Terphenyl
Benzo(e)pyrene
Indeno(1,2,3,cd)pyrene
Dibenzo(b,def)chrysene
Naphtho(1,2,3,4,def)chrysene
Benzo(rst)pentaphene
Benzo(ghi)perylene

Fencllyl alcohol

ketone

2-Hydroxy-4-methoxyacetophenone
2-Hydroxy-6-methoxyacetophenone

23527-10-8

Isopimaric acid

5835-26 7

Abietic acid
Abietic acid, meth ester
Dehydroabietic acid

514-10-3
127-25 3
1740 19-8

Isopimaric acid, methyl ester

86 06-6
1321-94 4

Dehydroabietic acid, methyl ester
7-0xodehydroabietic acid

28804-88-8
605-02-7
26140-60-3
192-97-2
193-39-5
189 64-0
----189-55 9
191-24-2

21657-70-5
1632-73-1

3730-56-1

Sandaracopimaric acid (lsodextropimaric acid)
Sandaracopimaric acid, methyl ester

535-77-3

15019-71-3
18317-90-3

(anti)

Pimaric acid, methyl ester

7-Oxodehydroabietic acid, methyl ester
Chlorodehydroabietic acid
Clllorooxodeiwdroabietic acid
Neoabietic acid, methyl ester
B -Sitosterol

1686 54-0

1686-62-0

1235-74-1
18684»55-4

17751-37-0
22478-66-6
38012-02-1
3310-97-2
83-46-5

MISCELLANEOUS
Dimethyl sulfide
Dimetlxyl disulfide
1,3,5-Trithiolpentane
1,2,S.6-Tetrathiolhexane

KETONES
Hethyl-tert butyl

26462 74-8

l-Chloro-Z-norbornene
1,2,3,4,7-Pentachloro-Z-norbornene (syn)

AROMATIC HYDROCARBONS
536-74-3

8013-00-1

Epijuvabione

25323-41-5

Phenylacetylene

120-83-2

TERPENES AND DERIVATIVES

877-11-2

a.a1,3,4,5,6-Heptachlorostyrene
1.2,3,4-Tetrachloroanthracene

106-48-7

(2,4-)

81 19-5

87-83-2

85-68~7

(4-)

608-93-5

Pentabrunotoluene

Chloroxylene
Hexachlorostyrene

Phthalic acid, butylbenzyl ester

501-52-0
882 09 7
69335~86 0

7 -97-8

Chloroaniline (2-)

55241-0
703 23-1

(3-)
(4-)

75-18-3
624-92 0
34202-58-9
58510-13-7
95-51 2

10542-9
106-47-8

2-Nydroxy-3-methoxyacetophenone

703-98-0

Trichlor oanlllne (2.4.5-)

636-30~5

2 Mechoxy-1-(4-metnomhenyi )ethanone

21160-26~9

G-Methyl 2-benzothiazolethiol

2268-79-3

Z~Hydroxy-5-nethoxyacetophenane
4-Hydroxy-3-methoxyacetonhenone (Acetovanillone)
Dimethoxyacetophenone (2,4~)
(2.5-)
(2.6-)
(3.
2-Chloro-l-pheyul-l-propanone
4 Hydroxy-3-nethoxypropiophenone
Dichlorobenzophenone (Z,2'-)
(3,3' )

4.4K)
1-(2,2',4' irichloro[1,1'-3ipneny1]-4-y1)ethanone
2.2 Dichloro-1-(2 -Chloro[l,l'-Biphenyl]-4-yl)ethanone
Vanillone

705-15-7
498-02-2
5329 20-9
1201-38-3
2040-04-2
1131-62-0

2 . 4 .5-)
Pentachloroaniline
N-Etiwldnih' e
N.N-Diethylaniline
Z-Methylbensz)thiophene
6-Benzothiazolol

6084-17-9
1835-14-9
5293-97 0
7094-34-0

Chloroindole (2 )
(34
(4-)
(5-)

90-98-2
39249-73-5
59612-59-8
575-23-7

Homovanillin
u -Phenylbenzeneacetaldehyde

2-Chloro-u-Phenylbenzeneacetaldehyde

2-Chloro a (Z-chlorophenyl )benzeneacetaldehyde)
2 Chloro-a-(4 chlorophenyl )benzeneacetaldehyde
4-Chloro-u-(4-chlorophenyl )benzeneaceta'l dehyde
Syringaldehyde

Chlorosyringaldehyde

694-93-9
15853-964)
25235-35-2
17522-32-1

(6-)
Trimethylisocyanurate
Triphenyl phosphate
Diphenylnonylphenyl phosphate

17422-33-2
877-89 4
115-86-6
----

Stilbene oxide

17619-97-5

Diphevwlcmlylphenyl phosphate

ALDEHVDES

034' 93-5
527-20-8
103-59'5
91-66-7
1195 14-8
13599-84-3

----

5703-24 2
947-91-1

52999-73-2

51559-01-4
34877-75-3
18164-50-6
134-96-3
-----

4]

*

Based on available data on toxicity, use

and environmental levels.

7.3 DISCUSSION
The Committee has endeavoured to clarify the content and purpose of the
lists of chemicals it published in l98l.
It has also conducted a partial

re-evaluation of some compounds and provided additional information to aid
those jurisdictions with responsibilities for surveillance and monitoring

programs.

No further evaluations of Appendix E chemicals or those listed in

Tables 7.1 through 7.5, are forecast; however, the Committee will sustain its

commitment to evaluate the health implications of chemical substances found in
the Great Lakes Basin. Emphasis should now be placed by the jurisdictions on
gathering surveillance data for all chemicals in Table 7.3 and some in Table
7.5 of this report and obtaining up-to date quantity and use data from
industry.
7.4 RECOMMENDATIONS
The Committee recommends that:

l.

those chemicals listed in Table 7.3 of this report (1982) be
considered for immediate inclusion in surveillance programs and that
certain groups of chemicals listed in Table 7.5 be considered as
candidates for surveillance programs of limited scope;

2.

3.

a new comprehensive list of chemical substances present and their

levels in the Great Lakes Basin ecosystem be prepared as soon as
possible and that it be coupled with up-to-date quantity and use data
for chemicals manufactured, used or released in the basin; and

the Parties should again be urged to develop toxicity information for

the chemicals in Table 7.5, identified as contaminants and/or in
widespread use in the Great Lakes Basin.
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8. Recommendations
The Committee on the Assessment of Human Health Effects of
Great Lakes

Water Quality make the following recommendations:
8.l DRINKING WATER AND PUBLIC HEALTH CONCERNS
Chemical

Surveillance of drinking water supplies for new organic contaminants
must
be increased.
The Parties should augment present toxicology programs to study the
toxicity (including carcinogenicity) of chemicals identified in drinkin
g

water supplies within the Great Lakes Basin.

More emphasis should be placed on toxicity/mutagenicity studies of the

non-chlorinated organic chemical fraction from drinking water.

Microbiological

Modification of drinking water treatment plant operations should
be
undertaken with caution and on an individual basis following adequate
studies to determine:
a)

b)

the efficacy of the modified treatment process in removing
contaminants of concern; and

the impact of the microbiological quality of the product water both
at the plant, and more importantly, in the distribution system.

Point-of-use water treatment units should be used only where convent
ional
approaches are not applicable and then only with an adequate monitoring
program and regeneration/replacement schedule.
Additional research into the relationship between particulate

matter/turbidity and waterborne illness, especially in recreational
waters, be undertaken to determine whether improved particulate removal
during sewage and stormwater treatment should be recommended.

CD

Jurisdictions should be urged to recognize the need for the assessment of
chronic health problems from low level exposure to microbiological
contaminants.

.2 RECREATIONAL WATER QUALITY
l.

A more rational basis for out understanding of health risks from
swimming should be obtained through additional research. It appears
that safe waters for swimming can be provided without excessive
reliance on the chemical disinfection of wastewater effluents.

.3 IMMUNOTOXICITY
l.

Adequate test systems need to be developed to measure the effects on

the immune system resulting from low level, chronic exposure to

chemicals.
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A11 chemical products do not need to be tested for immunotoxicity.
However, at least basic evaluation for potential effects on the
immune system should be carried out on those chemicals for which

there will

be significant human exposure.

8.4 ROUNDTABLE ON DATA REQUIREMENTS FROM SURVEILLANCE AND MONITORING PROGRAMS
General

It is recommended that the jurisdictions of the Great Lakes Basin:

1.

recognize the need to assess the chronic health implications and the
impact on reproduction of low level exposure of residents of the
Great Lakes Basin to environmental chemicals;
increase the comparability of their data by:

a)
b)

a)

b)

more frequent interagency communication and review of sampling,
analytical and assessment methodologies; and
implementing quality assurance programs;

report to the IJC at least annually the findings of surveillance
and monitoring programs on the Great Lakes and provide complete
details of sample collection, handling and analysis; and
meet annually to discuss the significance of the data
forthcoming from surveillance and monitoring programs and to
propose changes in future programs as deemed scientifically
appropriate.

evaluate their surveillance and monitoring programs that provide data
pertaining to public health, in terms of the specific requirements

listed in the proceedings of the Roundtable and alter their programs
as required.

Surveillance and Monitoring of Fish and Water for Organic and Inorganic
Chemicals:
It is recommended that the jurisdictions of the Great Lakes Basin:

5.

consider immediately surveillance for those chemicals identified by

the Committee on the Assessment of Human Health Effects in Table 7.3

of its 1982 Report but not to the exclusion of those listed in Table
7.5 of the 1982 Report;

address the issue of the human health impact of chemicals in drinking

water;

a)

conduct compliance monitoring programs of commercial and sport

b)

augnent surveillance programs for the identification of "new"
chemicals and the determination of trends of "old" chemicals;

fish species caught for consumption; and

continue to gather data on the fish consumption patterns of Great
Lakes Basin residents in order that monitoring programs can be
tailored to meet consumption patterns and health risk assessment be
based on sound exposure figures; and
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resolve the "edible portion

a)
b)

issue by

agreeing on a "standard" edible portion; or
conducting research on the relationships between different

protions of different species of fish such that data from
different jurisdictions can be compared.

Surveillance and Monitoring for Microbiological Contaminants in Water
Recommendations

It is recommended that the jurisdictions of the Great Lakes Basin:

l0.

ll.

a)

b)

improve their reporting of waterborne disease outbreaks; and

monitor, more frequently, effluent discharges in areas where
waterborne disease outbreaks have occurred;

investigate the hazard to health of bathing waters by
a)
ensuring that current monitoring programs for bathing waters are

b)
c)

utilizing the best indicators of contamination;
gathering data on those organisms identified as potentially

useful indicators of microbiological contamination of water; and
conducting research on the role between the microbiological

quality of bathing water sediments and the transmission of
disease to bathers.

8.5 UPDATE OF TABLES OF GREAT LAKES CHEMICALS PUBLISHED IN THE 1981 ANNUAL
REPORT

l.

Those chemicals listed in Table 7.3 of this report (l982) be
considered for immediate inclusion in surveillance programs and that

certain groups of chemicals listed in Table 7.5 be considered as

candidates for surveillance programs of limited scope.

A new comprehensive list of chemical substances present and their

levels in the Great Lakes Basin ecosystem be prepared as soon as
possible and that it be coupled with up-to-date quantity and use data
for chemicals manufactured, used or released in the basin.

The Parties should again be urged to develop toxicity information for

the chemicals in Table 7.5, identified as contaminants and/or in
widespread use in the Great Lakes Basin.
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APPENDIX 1

SPECIFIC SURVEILLANCE AND MONITORING REQUIREMENTS
FOR HUMAN HEALTH ASSESSMENT
Excerpts from the proceedings of the Rountab1e on the

Survei11ance and Monitoring Requirements for Assessing
Human Hea1th Hazards Posed by Contaminants

in the Great Lakes Basin Ecosystem

1.
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l.

SURVEILLANCE AND MONITORING FOR ORGANIC AND INORGANIC CONTAMINANTS IN FISH
l.l

Considerations

Monitoring programs that utilize fish tissue (or tissue of other biota)

are useful primarily for the detection and quantitation of lipid soluble

organic contaminants. Lipophilic contaminants (e.g. PCB, mirex,
hexachlorobenzene, DDE, etc.) often accumulate in individual fish;
concentrations of these contaminants in predatory species further up the food

chain are frequently several orders of magnitude above concentrations in

water.
Alkylated metal species (e.g. methyl mercury) and other metal
complexes may also be present in fish tissue; however, metallic ions rarely

accumulate in fish tissue to high levels and are more readily observed in

water and sediment.

There are three major objectives for fish surveillance and monitoring
programs that relate directly to public health concerns and one for monitoring

programs:
0

surveillance of fish species to identify new or previously

o

surveillance of fish species over time to establish temporal trends

o

surveillance of short-lived, local fish species to identify
point-sources of contamination

o

compliance monitoring of commercial and sport fish to determine

unrecognized contaminants; and

in tissue concentrations of well known contaminants.

whether or not fish residue levels exceed established guidelines;

For example, whole fish analyses provide data on the levels of numerous
toxic substances in the aquatic ecosystem and the levels are frequently 25% to
60% higher than those found in the edible portions of fish. Thus, the data
derived from whole fish are more frequently used for detecting trends in
contaminant levels and new contaminants and data from edible portion analyses
are used for compliance purposes.
These objectives dictate the type of fish chosen, the number and portion

analysed, the time, location and frequency of sampling and the analyses

carried out.

The following section provides details of program elements that must be
included if data arising from these programs are to be used for health hazard
evaluation.
l.2
l.2.l
0

Specific Requirements
Fish Species Sampled
Compliance monitoring programs must select fish that are consumed by
the public.
It is not necessary to analyse every sport and
commercial species from every location; however, the more commonly
caught species must be analysed.
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Surveillance for new, previously unrecognized

contaminantsor th

determination of trends requires the selection of long-lived top

predators ( e.g., lake trout, coho salmon) and forage species (e.g.,
rainbow smelt, chub).
Species selected should represent whole lake

conditions, i.e. they should be integrators of contaminants found

over a wide area.

Development of the use of nearshore species (e.g., spottail shiner)

capable of accumulating contaminants found in local areas (e.g., near
municipal water intake facilities) is encouraged.
l.2.2
0

Size Class and Sample Size
Compliance monitoring should provide data on a minimum of three (3)
size classes per species whenever possible. The size classes must be

representative of the usual range of sizes of that species caught for
consumption.

Selection of size classes that could be utilized by all Jurisdictions

would greatly improve comparability of data.

The large size classes of fish available should be utilized for the
identification of new contaminants in top predators.
the use of 4 + year old lake trout is recommended.

For example,

Current levels of contaminants in the Great Lakes and within species
variation indicate that sample size should not be less than 20

individuals of any one size class from any single location. A 20fish sample is capable of detecting a l0 20% change in most
contaminant levels in a species from one year to the next (GLISP).

Pools or composites of fish are acceptable when individuals of the

species are small (e.g. smelt, chub, shiner) or extraction of large

amounts of contaminants is required.
l.2.3
0

Location, Time and Frequency of Sampling

Sampling for compliance must take place where fish are caught for
consumption by the public, i.e., major sport fishing areas and

commercial fishery operations.

Sampling for compliance must also take place when fish are caught for
consumption by the public. Ideal sampling schedules should coincide
with peak catch periods for the various
speciesconsumed.
Frequency of sampling for compliance is dependent on the number of

peak catch periods per species. If variations in contaminant levels
within a species are minor between peak catch periods then sampling
of fish during all time perioos is unnecessary.
Localized areas known to contain or suspected to contain contaminants

at levels of concern to health should be surveyed more frequently
using appropriate nearshore and whole lake species.

Location, time and frequency of sampling of fish species for "old"

contaminant surveillance should be coordinated among the

jurisdictions to minimize duplication of effort and to enhance

_.I

comparability of data.
.2.4

Analytical Considerations
Compliance monitoring programs must analyze
"edibleportions" of fish
if they are to address health concerns. Definition of "edible

portion" has become a contentious issue within and between analytical
groups and jurisdictions and concurrence on a "standard edible
portion or the development of appropriate conversion factors is
urgently required to enhance comparability of data and consistency in
health hazard assessments.

Methods of analysis need not always be standardized, but rigorous
intra and interlaboratory comparisons via a sample check program are
essential to retain public confidence in analytical capability and
ensure the validity of analysis results. Participation in existing
and future quality assurance programs is strongly recommended.

.2.5

Data Handling

Improved reporting of data is required to optimize its use.

Emphasis

must be placed on the reporting of "new" contaminants and trends in
levels of "old" contaminants for health officials to revise or
conduct preliminary assessments, to set guidelines and to recommend

changes in monitoring and surveillance programs. Summary reports of
surveillance and monitoring activities should be provided to the IJC
each year and should include details of sample collection, processing
and analysis.
A central registry of data for contaminants in fish in the Great

Lakes would be useful for all jurisdictions. Currently there are
several computerized data bases in the jurisdictions that handle fish

contaminant data, e.g., OFIS (Ontario Fish Information System) in
Ontario and STORET in several states. A data system should be

_l

capable of providing rapid retrieval of information.

.2.6

Other Considerations
It is essential to have information on the amounts (meal size and

frequency) of various fish species consumed by residents of the Great

Lakes Basin (males and females), the peak consumption periods and the

preferences of special groups, i.e., ethnic, religious,

socio-economic, native subpopulations, for certain species.

Application of this knowledge to the selection of species for
surveillance and monitoring and to the calculation of average intakes
of a variety of contaminants, will greatly enhance the relevance of
surveillance and monitoring programs to public health.
Tissue banking is of value for retrospective analyses of contaminant

levels (and past human exposure) and efforts to develop fish tissue
banks should continue. Special attention should be paid to the
storage conditions and their adequacy.
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2.

SURVEILLANCE AND MONITORING FOR ORGANIC AND INORGANIC CONTAMINANTS IN WATER
2.l

Considerations

In this century, the justification for the chlorination of water supplies
has been the perceived success in controlling microbiological pathogens.

Waterborne disease control is now taken for granted in most areas of North
America, hence the public's concerns have shifted and now focus on the

chemical quality of drinking water, i.e., the presence of environmental
contaminants (natural and anthropogenic) and use of water treatment chemicals

(e.g. chlorine, pH adjusters, alum, etc.) and of elective water additives
(e.g. fluorides).
The implementation of existing and proposed drinking water
guidelines does not imply the production of a drinking water of standard
composition, i.e., water with identical pH, hardness, taste, colour,
turbidity, odour and chemical content; rather, it promotes the production of

water with individual measured parameters that do not exceed acceptable levels.
The measurement of organic and inorganic chemicals in water is an
important monitoring tool for identifying exposure to humans. Since the
measurenent of exposure to chemicals consumed in fish is carried out directly
on fish tissues, the main requirements for surveillance and monitoring for
chemicals in water are in the raw and finished drinking waters. The impact of
recreational exposures to chemicals in raw water is considered relatively

minor and will not be considered further.

Analyses of raw and finished drinking waters are carried out on a routine
and special-case basis by the responsible jurisdictions as required by current
drinking water guidelines and regulations in the United States and Canada.
Limits for several organic chemicals have been established and are generally
met in current water supplies. Unfortunately, the results of most compliance
monitoring programs of finished water are reported as either mean values
(without data on sample size, sampling location or time the standard deviation

or standard error) or they are reported as percent of samples meeting the
drinking water guidelines. Thus meaningful calculations of exposure are
almost impossible.

The Province of Ontario is addressing this problem by

developing a system to record all sampling data from water treatment
facilities. It is hoped that this central facility will be able to provide
data useful for exposure calculations.

Compliance monitoring for known environmental

chemicals in every municipal

water supply is expensive and time consuming. Currently one analysis per year
per site is common and practical. Ideally, compliance monitoring programs
should adjust to allow for less frequent sampling of non-detectable

contaminants and increase the sampling frequency for those chemicals found at
unacceptably high levels.
When chemicals for which no guidelines have been established are

determined in appreciable quantities in water or are found in fish tissue

(indicating their presence in water) it is important that the jurisdictions be
able to conduct an assessment of the potential health risks and if indicated,

take appropriate action to reduce human exposure.

To conduct such an

evaluation the jurisdictions must have data on the levels and distribution of
the contaminant(s) in raw and finished water and data on the consumption
patterns (quantity, sources) of the exposed population. Often, sampling
frequency will need to be increased on a contingency basis to meet special

requirements for data.
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The objectives of surveillance and monitoring programs for water are
similar to those listed for fish sampling programs. Compliance monitoring is

extensive but local and considers mainly finished water.

Surveillance data On

levels of chemicals in raw waters are essential and can be compared data on
by
levels in finished water to determine what is removed and what is added
equally
is
s
chemical
water treatment facilities. Surveillance for "new"
important because not all chemical contaminants accumulate in tissue and may
not be identified in fish surveillance programs.

2.2

Specific Requirements
Hater To Be Analysed

2.2.l
0

Compliance monitoring for chemical contaminants in finished drinking
water should continue as described in jurisdictional guidelines suc
as are found in Guidelines for Canadian Drinking Water Quality l978
and the National Interim Primary Drinking Water Regulations, U.S.
EPA, l976.

0

Raw water supplies should be surveyed for levels of known
contaminants and the presence of "new" chemicals. Furthermore those
chemicals indicated in Table 7.3 of the l982 Health Effects Committee
Report should be included in analysis schedules.

Location and Frequency of Sampling

2.2.2
0

or
Compliance monitoring should take place at the treatment facility
red
monito
be
should
s
eristic
charact
the distribution centre. Water
basis. In
on a year-round basis but chemical parameters on a yearly
ring or
monito
onal
additi
m,
the event of a known contamination proble
surveillance should be considered.

0

water
Sampling of raw water should take place at some municipal

g
intakes in spring (during high runoff periods), midsummer (durin

high volume use of water) and winter (after water freeze-up).
presence or
Intakes to be sampled should be selected based on the
probable presence of contaminants of concern.

0

in areas of
Sampling of ground water supplies should be conducted

, dump sites,
known or potential chemical contamination (due to spills

runoff, industrial or municipal effluents, etc.).

2.2.3

0

Volume of Sample

ed
Large volume samples of raw water and occasionally finish

(e.g. using
water,should be obtained for chemical concentration

reverse
macroreticular ion exchange columns, rotoevaporation,

XAD-2

of otherwise
osmosis, etc.) to determine low concentrations
undetectable contaminants.

2.2.4

0

Analytical Considerations

among the
Methods of analysis need not always be standardized
jurisdictions are
jurisdictions provided data produced by the

ance program
comparable and there exists a rigorous quality assur
within and among laboratories.
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o

The development and testing of methodologies that detect and measure

levels of waterborne contaminants more accurately and efficiently
should be encouraged.

2.2.5

Data Handling

0

Monitoring data should appear as mean values per time perioa and

0

Compliance monitoring data and surveillance data pertaining to trends

state sample size, volume, standard deviation and standard error.
in "old" contaminant levels and to "new" chemicals in raw and

finished water should be reported to a central data collection

N

agency. Annual reports should be made available to the jurisdictions
and to the IJC.
.2.6

0

Other Considerations

Private water supplies may have low pH as a result of acidified rain

water and may cause extensive corrosion of some plumbing systems.

pH

is routinely adJUStQO in municipal water supplies, hence, these water
supplies are unlikely to contribute to the corrosion of household
plumbing.

0

Testing of water samples for mutagenicity may be useful for the

0

Although the contribution of waterborne chemicals (including those
added or formed during water treatment) to the total daily intake of

assignment of priority for further analysis; however, water samples
that show mutagenic activity are not necessarily harmful to health.

these substances via food and air is likely to be small, there is a

need to examine the overall long-term effects on human health of
exposure to these chemicals in water. This requirement by no means
alters the important need to disinfect drinking water supplies.
3.

SURVEILLANCE AND MONITORING FOR MICROBIOLOGICAL CONTAMINANTS IN WATER
3.l

Considerations

Prior to the initiation of disinfection practices, contamination of water
by pathogenic micro-organisms posed a major threat to human health.

Conscientious effort and innovation have reduced the incidence of serious,
wide-spread waterborne disease outbreaks in North America dramatically.

Waters (and sediments) may be classified into three groups on the basis of
the magnitude of the impact they are likely to have on human health.
Group 1.

Finished and raw drinking waters and bathing waters.

Drinking

water has the greatest potential to impact on health because it is

ingested in large quantity.
Bathing waters. Bathing water is also ingested and provides
extensive opportunity for dermal contact by microorganisms.

Surveillance programs designed to assess the impact on health of

bathing waters must examine both undisturbed water and bathing water
with bathers present. These two approaches allow assessment of the
background level of contamination entering or present in the bathing
area and the contribution of the bathers themselves to the microbial
load in the water.
54

Group II.

Discharges to lake waters.

Sewage and packing plant effluents

contribute to the total load of microorganisms and usuall
y contain

organisms which can produce disease in humans, but are less
likely to

be in a direct contact with man.
Bathing water sediments. There is currently little information on the
part played by bathing water sediments in the transmission
of
waterborne disease and the lack of standardized sampling and
analytical methodology makes interpretation of existing data
difficult.
Specific research that addresses the microbiological
characteristics of bathing water sediments is required prior
to
further assessment of the health hazard posed by this media.

Group III.

Open lake waters.

These waters have the least impact on human

health because human exposure to them is limited.

3.2

Specific Requirements

3.2.l

Parameters

The parameters for which measurements are required in the surveillance
and
monitoring of microbiological contaminants fall into three groups:
-

Parameters that are monitored on a routine basis (include organis
ms

which are used as indicators of the presence of human and/or animal

pollution and therefore, the presence of human pathogens);
-

Parameters that have the potential to be useful but for which,
currently, only a limited data base exists.
Insufficient information

is available as to the utility of some of these parameters for health
assessment, however, their inclusion into monitoring programs on a
trial basis should be encouraged; and
-

Parameters that measure waterborne pathogens (includes bacteria,
viruses and parasites).

The analytical requirements for each of these three parameter groups have
been tabulated using the classification of water into Groups I, II, and III.

0

Table l lists the water group and the common indicators of water
quality which are currently used. Each indicator organism is

assigned a numerical ranking to denote its utility for a given water

type, using I for essential parameters, 2 for very useful parameters
and 3 for useful parameters.

0

Table 2 lists those organisms that may be of potential use for health
risk assessment in the specific water groups shown. However,
sampling and isolation methods for these organisms have not been

refined or standardized and the interpretation of their presence in
waters in terns of human health impact remains equivocal. It is not
necessary to investigate open waters for these parameters. The
collection of more data on the occurrence of these microorganisms in
these specific areas will enable their ultimate role in human health

assessment to be determined.
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TABLE 1. ROUTINE PARAMETERS USED AS INDICATORS
OF MICROBIOLOGICAL CONTAMINATION OF WATER

CoTiforms

Group
TotaT
I
Drinking Water
Finished
1
Raw
-

Feca]a

Bathing Water
II

Escherichia Otherb

coli

CoTiforms

aeruginosa

I
l

l
1

3

3
3

-

1

1

2

2

2

1

3

Discharges

-

l

1

Bathing

-

1

1

III Open Water

1

3

-

Sediments

EnterococcusC Pseudomonas

1

3
-

_

a Confirmatory test if totaI C01iform 1eve1 is high.
Klebsiella, Aeromonas, Citrobacter, Enterobacter

C Standard Methods for the Examination of Water and Nastewater, 14th ed.,
APHA, Washington, D.C., 1976

N.B.

Parameters: l-essentia]; 2-very useful; and 3-usefu1

TABLE 2.

POTENTIAL INDICATORS 0F MICROBIOLOGICAL CONTAMINATION OF WATER

Staphylococcus

Group
aureus
Drinking Water
Finished
Raw
Bathing Water

X

Discharges

-

Bathing
Sediments

X

Clostridium

ORGANISM

Candida

perfringens

albicans

Coliphages

Bifidobacteria

X
X

-

X
-

X

-

X

-

X

-

X

-

X-recommendation for monitoring
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X

-

Where an epidemiological study of a specific waterborne outbreak is
undertaken, or where a defined population will be studied for
evidence of waterborne disease, it may be necessary to undertake

surveillance of one or more of the following waterborne pathogens:
Aeromonas hydrophila

- Giardia lamblia
- Schistosoma species

- Pathogenic amoeba

-

ampylobacter species

egionella species
Salmonella species

Enteric viruses

- Shigella species

- Yersinia enterocolitica

The isolation and sampling methodologies for these organisms in water
is not yet fully developed and in certain cases, the specific types
that are virulent for humans cannot be identified.
For these
reasons, interpretation of any isolations must be made with extreme
caution.

3.2.2

Location and Frequency

Monitoring of finished drinking water must be carried out to ensure
the safety of drinking water and to indicate that efficient treatment
procedures have been employed and that the integrity of the

distribution system has been maintained.

methoos are specified by

Minimum sampling regimes and

the various jurisdictions and these are

considered to be adequate at present. However, data on the levels of
residual chlorine at the time of sampling would be very useful.

Routine monitoring of raw drinking water should be carried out to

ensure that treatment methoas will be adequate to prevent finished

water contamination. The sampling frequency and method is specified
by the Jurisdictions; frequency will depend generally upon the
microbiological history, the season of the year, the potential
sources of pollution and the population at risk.

Minimum sampling frequencies for recreational waters are determined
by the Jurisdictions and in general adequately address health risk
assessment for the duration of the recreational season. It should be
recognized that a sanitary survey of an area is an essential
component of any assessment of the health hazard to bathers. Samples

of bathing beach water should be collected at representative areas at
each beach and upstream of areas subject to influence from point

source discharges. Multiple individual samples are preferred, but
composite samples may be useful in screening programs. Routine
sampling should be at a depth of l5-30 cm below the surface of water
that is l-l.5 m deep. In intensive sampling, water should be
collected at various depths in the water column, throughout the
defined bathing area. To better define bather contribution, samples

(This film not
from the surface film of the water may be useful.
body Oils and
the
only would tend to concentrate organisms shed with
secretions, but is the area of water most usually in contact with the
eyes, ears, nose and mouth of the bathers). The conditions under
which samples are collected should be recorded, with such details as
the estimated bather load at the time, so that appropriate
interpretation of the results can be made.
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Point sources of potential microbial pollution that are likely to
impact on human health, by contamination of raw drinking waters or
bathing waters, etc. should be monitored in order to identify types
of microbial contaminants and their numbers, as well as to determine

compliance with effluent discharge objectives.

Monitoring of

effluents for microorganisms is important in the determination of the

degree of pathogen elimination achieved by treatment processes;

however, not all of the jurisdictions in the Great Lakes Basin have

set bacteriological limits for their sewage and industrial effluents
and monitoring of this type is sporadic.

3.2.3

Analytical Considerations

Sampling and analytical procedures for identification and

quantitation of microbiological parameters should be as standardized
as possible between the Jurisdictions.

3.2.4

Data Handling

The methoo of sample collection and analysis should be provided with
all data.
The poor quality of waterborne disease reporting is a problem common
to all the jurisdictions and affects assessments of the health impact

of water used for drinking and recreation. With the possible
exception of Pennsylvania, investigation of suspected waterborne

outbreaks of disease is not vigorously pursued and reporting tends to

be inaccurate and fragmented among the various agencies concerned.

More frequent and more complete reporting of waterborne disease
outbreaks should be implemented. An annual summary report to the IJC

is recommended.
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APPENDIX 2
A.

SPECIFIC CHANGES TO TABLES 4 AND 5 OF THE 1981 ANNUAL REPORT
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Specific changes made to Table 4.

Table 7.4, has been prepared using Table 4, 1981, as its base. Chemicals that were
listed in 1981 and do not appear in 1982 are listed as "deletions". Chemicals that did
not appear on the 1981 table but have been added this year are listed as "additions".

Chemicals have been added or deleted for four basic reasons:
the chemical was listed
twice in Table 4; the chemical has been re-evaluated and moved to Table 7.4; the

chemical was accidentally omitted or mistakenly included in 1981; or the chemical has
been renamed (the old name deleted and the new name added).

of isomeric forms of any

The addition to Table 7.4

one chemical has not been relisted below.

ADDITIONS

RATIONALE

Acetophenone

Unlikely to pose a health hazard,
rapidly degrades in the environment.
Appeared in Table 5, 1981.

Carbofuran

Carbamate insecticide, rapidly degraded
in the environment and unlikely to pose

a long-term health hazard. Omission from
Table 4, 1981, was an error.
N,N-Dimethylaniline

Mistakenly listed in parentheses after
Dimethyl adipate in Table 4, 1981.

Docosanoic acid

Unlikely to pose a health hazard, similar
properties to other short chain acids.
Appeared in Table 5, 1981, as Arachidic
acid.

l-Dodecanol

Unlikely to pose a health hazard, similar

Eicosanoic acid

Unlikely to pose a health hazard, similar

properties to other short chain saturated
alcohols. Appeared in Table 5 1981.
properties to other short chain acids.

Appeared in Table 5, 1981, as Behenic acid.
Heptene

Unlikely to pose a health hazard, similar
properties to other short chain alkenes.
Appeared in Table 5, 1981.

9- Octadecenoic

Unlikely to pose a health hazard, similar

acid, methylester

properties to other short chain esters.

Appeared in Table 5, 1982, as Methyl

linoelaidate (incorrectly named)

Phenol

Rapidly degraded, few long term effects.

Water quality objective based on taste.
Omission from Table 4, 1981, was an error.
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DELETIONS

SPECIFIC CHANGES TO TABLE 4 (CON'T)

ADDITIONS

RATIONALE

DELETIONS

Tetracosanoic
acid

Unlikely to pose a health hazard, similar
properties to other short chain acids.
Appeared in Table 5, 1981, as Lignoceric acid.

Vanadium

Unlikely to pose a health hazard after longterm, low level exposure.
See Summary

Evaluation in 1981 Report.

Table 5, 1981, in error.

Appearance in

Already appears as Tetradecanoic acid in

Myristic acid

Already appears as Hexadecanoic acid in
Table 4, 1981.

Palmitic acid

A class of compounds and not an individual
chemical with a CAS number

Terpene

Table 4, 1981.

3enzo(k)fluoranthene

Renamed

Benzo(k)
fluoranthrene

Z-Butanone

Renamed

Methyl ethyl
ketone

2-Buten-l ol

Renamed

But-Z en-l-ol

Dibenzo (def,mno)

Renamed

Dibenz (def,mno)

chrysene

chrysene

Oicamba

Renamed

3,6 Dichloro-2
methoxy benzoic
acid

Dichlorobromofluoro
methane

Renamed

Fluorodichlorobromomethane

1,2-Dihydro-6Methylnaphthalene

Renamed

Methyl dihydro
naphthalene

9,10-Dihydroxy

Renamed

Methyl dihydroxy

octadecanoic acid,

sterate

methyl ester

"

L;

s a;

Dodecanoic acid,
methyl ester

Renamed
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Methyl laurate

SPECIFIC CHANGES TO TABLE 4

ADDITIONS

(CON'T.)

RATIONALE

DELETIONS

Eicosanoic acid,
methyl ester

Renamed

Methyl
arachidate

2 Ethylhexanoic acid
methyl ester

Renamed

Methyl ethyl
hexanoate

Fluoranthene

Renamed

Fluoranthrene

9-Hexadecenoic acid

Renamed

Palmitoleic acid

Hexanedioic acid

Renamed

Dihexyl adipate

Hexanedioic acid,

Renamed

Dimethyl adipate

Hexadecanoic acid,
ethyl ester

Renamed

Ethyl palmitate

Hexadecanoic acid,
methyl ester

Renamed

Methyl palmitate

Methacrylic acid,
methyl ester

Renamed

Methyl
methacrylate

4 Methyl 2-

Renamed

Methyl isobutyl

9,12 0ctadecadienoic
acid

Renamed

Linoleic acid

9 0ctadecenoic acid (cis)

Renamed

Oleic acid

Octadecanoic acid,
methyl ester

Renamed

Methyl

9,12,15-0ctadecatrienoic acid,
methyl ester

Renamed

Methyl
linolenate

Phthalic acid, butyl

Renamed

Butyl phthalyl

Phthalic acid,

Renamed

Dibutylphthalate

Tetradecanoic acid,
methyl ester

Renamed

Methyl myristate

dihexyl ester

dimethyl ester

pentanone

ester, ester with
butylglycolate
dibutyl ester
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ketone

stearate

butylglycolate

Specific Changes to Table 5.
Table 7.5 has been prepared using Table 5, 1981, as its base. The majority of
changes involve deletions from the old table for the following reasons: the chemical
was re evaluated and assigned to another table; the chemical was listed twice in
Tables 2 through 5, 1981. Although a large number of chemicals have been renamed,

the addition to Table 7.5 of isomeric forms of any one chemical has not been relisted
below.

ADDITIONS

RATIONALE

DELETIONS

Incorrect name, already appears in Table

6,8,11,13
Abietate-triene
l8 oic acid

Unlikely to pose a health hazard, moved to
Table 7.4.

Acetophenone

Unlikely to pose a health hazard, moved to
Table 7.4 as Eicosanoic acid.

Arachidic acid

Moved to Table 7.4, see Summary Evaluation

Atrazine

Unlikely to pose a health hazard, moved to

Behenic acid

Moved to Table 7.3, see Summary Evaluation.

Benzo(b)

Moved to Table 7.2, see Summary Evaluation

Benzolj)

A trihalomethane, moved to Table 7.2.

Bromodichloromethane

A trihalomethane, moved to Table 7.2.

Bromoform

A trihalomethane, moved to Table 7.2.

Chlorodibromo
methane

Moved to Table 7.3, see Summary Evaluation.

Cresol

Covered under Polychlorinated biphenyl
in Table 7.2.

Decachloro

Double listed in Table 2 and 5.
listed in Table 7.2.

Diazinon

7.5 as Dehydroabietic acid.

Table 7.4 as Docosanoic acid.

Correctly

Already appeared in Table 7.5 as chlorodibromomethane, moved to Table 7.4 as
chlorodibromomethane
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fluoranthene
fluoranthene

biphenyl

Dibromochloromethane

SPECIFIC CHANGES TO TABLE 5 (CON'T.)

ADDITIONS

RATIONALE
Not a specific compound with a CAS number.

DELETIONS
Dichlorocyclo
diene resin
acids

Moved to Table 7.3, see Summary Evaluation
Appears already in Table 7.4 as 3,4-

Dimethoxyacetophenone.

1,2-Dichloroethylene
Dimethoxyaceto
phenone

Unlikely to pose a health hazard, moved
to Table 7.4.

l-Dodecanol

Moved to Table 7.3, see Summary Evaluation.

Endosulfan

Double listed in Tables 5 and 2.
Currently listed in Table 7.2.

Heptachlor

Currently listed in Table 7.2.

Double listed in Tables 5 and 2.

Heptachlor
epoxide

Unlikely to pose a health hazard,

Heptene

A trihalomethane, moved to Table 7.2.

Iododichloro
methane

Appears already in Table 7.4 as Dodecanoic
acid.

Lauric acid

Unlikely to pose a health hazard, moved

Lignoceric acid

Appears already in Table 7.4 as Guaiacol

Methoxyphenol

Appears already in Table 7.4 as Guaiacol.

o Methoxyphenol

Appears already in Table 7.4 as

Methylanthracene

Appears already in Table 7.4, renamed
1,2-Dihydro 6-methyl naphthalene

6-Methyl-1,2-di-

Appeared already in Table 4 as Methyl-

Methyl 9,10dihydroxy

moved to Table 7.4.

to Table 7.4 as Tetracosanoic acid.

Methylanthracene

dihydroxy stearate and has been renamed
9,lO-Dihydroxy-octadecanoic acid, methyl

ester in Table 7.4
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(1-,2- and 9 )

hydro

naphthalene

ester

SPECIFIC CHANGES TO TABLE 5

ADDITIONS

(CON'T.)

RATIONALE

DELETIONS

Appears already in Table 7.4 as
Dichloromethane.

Methylene
chloride.

Appears in Table 7.4.

lO Methyl
eicosane

Appears already in Table 7.4 and has been
renamed Z-ethylhexanoic acid, methyl ester

Methylethyl Z
hexanoate

Appears already in Table 7.5 as Methyl 7-

Methyl-7 ketode-

Unlikely to pose a health hazard, moved
to Table 7.4 as 9 0ctadecenoic acid, methyl

Methyl

Appears already in Table 5 as Cresol, moved
to Table 7.3.

2-Methyl phenol

Appears already in Table 7.5 as
Pentachloroanisole

Methylpentachlorophenyl ether

Appears already in Table 7.5 as
Tetrachloroanisole

Methyltetrachloro

Appears already in Table 7.5 as
Trichloroanisole

Methyltrichloro

Not a specific compound with a CAS
number

Monochlorocyclodiene resin acids

Included under chlorinated naphthalene
in Table 7.3.

Octachloro

Appears already in Table 4.

Pinene, a- and B-

Not a specific compound with a CAS
number

Tetrachlorocyclodiene resin acids

Not a specific compound with a CAS

Trichlorocyclo-

Appears already in Table 7.5 as 3,4,5-

Trichlorodimethoxy phenol

Appears already in Table 7.4 as Pinene

Trimethylbicyclo3,11-heptene

oxodehydroabietate

ester (trans) (Methyl elaidate).

number.

Trichloroveratrole
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hydroabietate

linoelaidate

phenyl ether

phenyl ether

naphthalene

diene resin acids

SPECIFIC CHANGES TO TABLE 5

ADDITIONS

(CON'T.)

RATIONALE
Uniikeiy to pose a heaith hazard, moved
to Tabie 7.4.

DELETIONS
Vanadium

Abietic acid,
methyi ester

Renamed

Methyi abietate

6 Benzothiazoioi

Renamed

Hydroxy benzo

Buty]benzene(n, sec-,

Renamed

Aikyi benzene

2 Chioro-a-(4chiorophenyi)

Renamed

Diphenyiacetaidehyde, dichioro

4-Chioro-1,2-

Renamed

Chioroveratroie

Chiorophenoi
(2-,3-,4 )

Renamed

Monochiorophenoi

2-(4-Ch10rophenoxy)

Renamed

Methy1-2(4-ch10ro

tert-) and Isopropyi

thiazoie

methyibenzene

benzeneacetaidehyde
dimethoxybenzene

butanoic acid,

derivative

methyl ester

phenoxy)

butanoate

2-Ch10ro-a-pheny1
benzeneacetaidehyde

Renamed

Diphenyiacetaidehyde, monochioro
derivative

2-Ch10ro 1-pheny1-lpropanone

Renamed

Chioropropiophenone

DMPA

Renamed

Zytron

Dichioroanisoie

Renamed

Methy] dichlorophenyi ether

1,2-Dich10ro 4,5

Renamed

Dichioroveratroie

dimethoxybenzene

Dichioromethoxy phenoi Renamed

Dichioroguaiaco]

Dehydroabietic acid,

Renamed

methyi ester
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Methy1

dehydroabietate

SPECIFIC CHANGES TO TABLE 5

ADDITIONS

RATIONALE

(CON'T.)

DELETIONS

Ethion

Renamed

B Hexachlorocyclo
hexane

Renamed

diethylurea
B-Benzene hexachloride

Isopimaric acid,

Renamed

Methyl

Renamed

Methyl thiobenzo

2 Methoxy-1 (4methoxyphenyl)

Renamed

Acetovanillone

Neoabietic acid,
methyl ester

Renamed

Methyl
neoabietate

7-0xodehydro
abietic acid,

Renamed

methyl-7-oxodehydroabietate

a-Phenylbenzeneacetaldehyde

Renamed

Diphenylacetaldehyde

Phthalic acid, butylbenzyl ester

Renamed

Butylbenzyl
phthalate

Phthalic acid,

Renamed

Diethyl

methyl ester

6 Methyl 2-benzo
thiazolethiol

N (3,4-dichloro

phenyl) N,N

isopimarate

thiazole

ethanone

methyl ester

diethyl ester

Phthalic acid,

dimethyl ester

Renamed

phthlate
Dimethyl

phthalate

Phthalic acid,

Renamed

Pimaric acid,
methyl ester

Renamed

Methyl pimarate

Sandaracopimaric
acid, methyl ester

Renamed

Methyl sandaracopimarate

Stilbene oxide

Renamed

Trans-stilbene
oxide

dioctyl ester
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Dioctyl

phthalate

SPECIFIC CHANGES TO TABLE 5

ADDITIONS

(CON'T.)

RATIONALE

DELETIONS

Tetrach10romethoxy

Renamed

Tetrach1oro-

1,2,5,6-Tetrathio1-

Renamed

Tetrathio

1,2,3 Tr1ch1oro 4,5dimethoxybenzene

Renamed

3,4,5-Trichloroveratro1e

Trich1oromethoxy
pheno]

Renamed

Trich1oroguaiac01

phenol

hexane

guaiacol
hexane

1-(2,2',4'-Trich10ro[1,1'-Bipheny1] 4-y1)ethanone; and
2,2-Dich10ro 1 (2'-Ch1oro[1,1'-Bipheny1] 4-y1)ethanone

Diphenylacetal-

Triethy1eneg1yco1ethy1 ether

Renamed

2 (2-(2 ethoxy
ethoxy)
ethoxy)
ethano]

1,3,5-Trithio1pentane

Renamed

Trithiapentane

Renamed
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Atrazine

(CAS Reg. No. l9l2 249)

(Table: 7.4)

Exposure profile:

This herbicide has been detected in agricultural watersheds tributary
to Lake Erie (up to l0 pg/l) and in Lake Erie sediments (20 ng/g).
Significant amounts are handled in the Great Lakes Basin.
Toxicity profile:

Oral L050:

l.75 to 3.08 g/kg in various rodent species (l).

Carcinogenicity:

Mice dosed orally with 2l.5 mg/kg/day for 80 weeks

exhibited a hepatoma incidence of 5.6 percent versus 4.24 percent for

controls. (3)

Chronic Adverse Effects: Rats fed 500 ppm atrazine in the diet for 6

months exhibited a retardation in growth which was partially due to

reduced food intake.
(l09).

Histological examination revealed no lesions

CNS Effects: Rats administered oral and interperitoneal LDso levels of
l,400 and l25 mg/kg, respectively, showed excitation followed by
depression with reduced respiratory rate, motor incoordination,
clonic and sometimes tonic spasms and hypothermia (ll2).
Reproductive Effects:

Subcutaneous injection of 800 mg/kg/day on days 3, 6 and

9 of gestation resulted in death and resorption of some or all of the
pups in each rat litter. Dosages as high as 200 mg/kg/day dld not
affect the number of pups per litter nor their weight at weaning
(ll3).

Teratogenicity: No data found.
Mutagenicity: Mutagenic in some, but not all, tests in Drosophila melanogaster
(llO). Atrazine was not mutagenic in yeast or Aspergillus sp with or

without addition of activated mouse liver microsomal enzymes (lll).

Permissible Exposure Limit: Acceptable da3ly intake is calculated to be 0.0375
mg/kg/day (ll7). TLV is l0 mg/m (43).
Immediately Dangerous to Life or Health: Probable lethal dose in humans
0.5-59/kg or between l 02. and l pint for a 70 kg. person (74).

Existing Environmental Regulations: None known.
Recommendation:
aSin.

Atrazine is used in moderate quantities in the Great Lakes
Its acute and chronic toxicity for mammals is low. Although

data on levels of atrazine in biota and media are few, there appears

to be very little in the environment.

Atrazine is unlikely to pose a

health hazard to residents of the Great Lakes Basin at this time.
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Benzo (b and j) fluoranthene

(CAS Reg. No. 206 99-2
and 205-82-3)

(Table: 7.3)

Exposure profile:

Both Benzo(b) and Benzo(j) fluoranthene are found in the exhaust of

gasoline engines and in cigarette smoke. They have been detected in
air, water and soil.
Both have been reported in food at mg/kg levels

(63).

Toxicity profile:

Oral L050: No oral acute toxicity data found.

The minimal

toxic dose

(TDLO) for mice painted with B(b)F is 40 mg/kg and 3l2 mg/kg (l)

with B(j)F.
Carcinogenicity:

Benzo(b) fluorantheneIn an
were skin painted three times
acetone. After 8 months, lOO
carcinomas. Treatment with a

experiment with no control group, mice
weekly with 0.5 percent B(b)F in
percent had papilloma's, 90 percent
0.l percent solution caused 65 percent

of the mice to develop papillomas and 85 percent carcinomas after l2

months.

Fourteen months of treatment with a 0.0l percent solution

produced papillomas in l0 percent of the mice (63). B(b)F has not
been tested in other species or by other routes (63).
Benzo(j) fluoranthene- 95 percent of mice painted 3 times weekly with
0.l percent or 0.5 percent B(j)F in acetone developed carcinomas
after 7 to 9 months of treatment. Papillomas were also observed.
B(j)F has not been tested in other species or by other routes (63).

Chronic Adverse Effects: No data found other than carcinogenicity results.
CNS Effects:

No data found but unlikely to cause CNS effects.

Reproductive Effects: No data found.

reproductive anomalies (55).

Teratogenicity: No data found.

Other PAH's like benzo(e) pyrene cause

Benzo(e) pyrene is a suspect teratogen (l5).

Mutagenicity: No data found but unlikely to be highly mutagenic.

Permissible Exposure Limit: Not established.
Immediately Dangerous to Life or Health: Not established.

Existing Environmental Regulations: The WHO has recommended a maximum of
0.2 pg total PAH/L in water.
Recommendation:

Benzofluoranthene is produced from a wide variety of

combustion sources and is ubiquitously distributed and results
from a wide variety of combustion sources. Like other PAH s,
benzo(b) and benzo(j) are likely to be skin carcinogens. Levels of
PAH's should be determined in water, fish and air.
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Cresol (o ,m-,p-)

(CAS Reg. No. l3l9773)

(Tables: 7.l and 7.3)

Exposure profile:

Large amounts of cresols (> 105 kg) are used in the Great Lakes

Basin annually by the chemical industry.
the environment was available.

No information on levels in

Toxicity profile:

Oral LDso:

861-2000 mg/kg in various rodent species. (l)

Carcinogenicity:

Twenty two

dermal applications over ll weeks of cresol

isomers (as a 20 percent solution in benzene) mixed with

DMBA (in

acetone) to mouse skin resulted in a relative increase in the
numbers
of mice with papillomas compared to DMBA treated controls.
No

Carcinomas were observed.

Cresol is a tumor promotor in mice (ll4).

It has not been tested neat.

Chronic Adverse Effects: Chronic poisoning from oral or percuta
neous
absorption may produce digestive distrubances and nervous disorders,
vertigo, mental changes, skin eruptions, jaundice, oligur
ia and

uremia. (67, ll8)

CNS Effects: Rabbits exposed dermally to any of the three isomers in doses
of
1 ml/kg for 24 hrs. exhibited the following CNS effects: salivation,
lacrimation; hypoactivity, tremors, convulsions, sedation and
death

(ll5). Cresol exposed workers developed headache, nausea and
occasionally convulsions. (ll6)
Reproductive Effects: No data found.

Teratogenicity: No data found.

Mutagenicity: No data found.
Permissible Exposure Limit: ACGIH gives a TLV value of 5 ppm. or 22 mg/m3

but specifies for exposure to skin.

(43)

Immediately Dangerous to Life or Health: Lethal dose in humans has been

estimated to be 50 500 mg/kg (74) and lOg (ll9).

Existing Environmental Regulations: In as much as cresol is a phenolic
compound, there is a Canadian Drinking Water Guideline (based on

odour) for phenols of 2 pg/L.

Recommendation:

Large amounts of cresols are used in the Great Lakes Basin

ut little is known about levels in the environment.

Cresol

is not

particularly toxic after acute exposure, however it may be a tumor

promotor after skin contact. Surveillance of industrial effluents
and nearshore water is recommended to determine levels.
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Immediately Dangerous to Life or Health: For l,2 DCE, 4000 ppm (OSHA) (42).

Existing Environmental Regulations: None found.
Recommendation:

Dichloroethylene is used in large quantities in the basin and

the l,2-DCE has been reported in water. Although there are few
chronic toxicology data, l,l-DCE has been identified as an animal
carcinogen.
Surveillance for l,2-DEC is recommended to determine
levels in industrial effluents and water.
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Endosulfan

(CAS Reg. No. 2157l99)

(Tables: 7.l & 7.3)

Exposure profile:

This agricultural pesticide is found in the water
column (0.002 to

0.25 ug/L, form predominant) in sediments (up to l6.0 pg/g dwt,
a and B forms) in air (up to l.0 ppt) and rainwater (2.0
ppt, B
form predominant).

Usage is 2.8 million pounds in New York alone.

Use is by licensed application (which includes farmers)
and is

essentially without restrictions.
Typical applications are in potato
and tomato production.
The compound is transformed by microbes to
endosulfandiol, but probably is not completely mineralized.

Endosulfan is practically insoluble in water; data on
bioaccumulation

were not available from ISHON.

Toxicity profile:

Oral L050: 2mg/kg in cats and l8 ll8 mg/kg in rodents. (l)
Carcinogenicity:

An NCI-sponsored bioassay indicates that endosulfan
is not

an animal carcinogen under the conditions of the study
(3)

Chronic Adverse Effects: When rats were given l00 ppm of
endolsulfan in
their diet for 2 years, adverse effects included:
decreased
Survival; decreased weight gain; decreased teste
s weight; and

significant renal tubular damage (22).
CNS Effects:

Occupational

exposure to endosulfan dust has been reported to
cause confusion and excitement (4) and epileptiform convul
sions (l2l).

Reproductive Effects: A three-generation repro
duction study showed no effect
on the reproduction performance and survival indices
of rats

maintained on a diet containing 50 ppm of endosulfan
(2l). However,
oral dosages of 5 mg/kg/day and greater on day 6-l4 of
gestation
resulted in increased mortality of rat dams and
increased fetal
resorptions and skeletal anomalies (l07).
Degenerative changes in

semeniferous tubules and a significant decrease in
testicular weight
were observed in male rats fed l5 mg/kg/day (l08).
Teratogenicity: When administered orally to pregnant
rats (5 mg/kg) on days
6-l4 of gestation, endosulfan induced skeletal terata in
fetuses
(l07).
Mutagenicity: Not mutagenic in a dominant lethal study
with mice (l03) in vitro
tests (l04) or in tests in rats desi ned to determine
effects on

somatic and germinal cells (l05, lOG).

Permissible Exposure Limit: O.l mg/m3 for skin (43).
Immediately Dangerous to Life or Health: Probable
lethal dose in humans

is 50-500 mg/kg (74).
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Existing Environmentai Reguiations: None known.
Recommendation:

'_

Endosuifan has significant acute and chronic toxicity for man,

w _ and it is used extensively in the Great Lakes Basin (>iO6 kg/
annum).

Little is known of its environmentai fate.

Surveiiiance for

Endosuifan is recommended in fish and water to determine ieveis and
trends.
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